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ABSTRACT 
Most Salmonella enterica serovars are believed to have a cyclical lifestyle involving both 
host-associated and environment-associated, persistent phases. Their ability to persist in the 
environment increases the probability that they will be transmitted. Our hypothesis is that the 
genetic factors required for cellular aggregation and biofilm formation are important for host-to-
host transmission. A link between biofilm formation, environmental persistence and 
transmissibility has not been observed, due to the lack of an appropriate model. 
We developed a murine model of Salmonella transmission allowing us to study the 
genetic factors involved in the transmission process. To test the role of aggregation and biofilm 
formation we used the ∆csgD mutant, which is deficient in both processes. We also engineered 
luciferase reporter strains of Salmonella enterica serovar Typhimurium (Salmonella 
Typhimurium) to track infection within a mouse population before the onset of clinical signs 
using bioluminescent imaging. 
We determined that mice shed high levels of Salmonella Typhimurium in their feces 
when pre-treated with streptomycin. To observe the transmission efficiency of Salmonella, we 
tracked their spread from infected mice to naive mice, and determined that Salmonella could be 
transmitted only after pre-treatment with streptomycin. We compared the shedding potential and 
colonization levels of mice challenged with either wild-type Salmonella Typhimurium or the 
∆csgD mutant and determined them to be statistically similar when challenged separately. We 
found that wild-type Salmonella Typhimurium persisted in fecal pellets at higher levels than the 
∆csgD mutant. We compared both the short- and long- transmission potential of the ∆csgD 
mutant to wild type Salmonella Typhimurium, and found that the mutant did not have a defect in 
either process. 
Though not observed in our model, we believe that environmental persistence and 
biofilm formation are important for the transmission of Salmonella due to its cyclical lifestyle.  
The model we generated remains useful to test the role of other genes in transmission. It can be 
further refined to more accurately mimic environmental transmission of Salmonella. Further 
understanding of the transition of Salmonella from infected hosts to the environment and back 
into new hosts will aid in reducing its environmental persistence and transmission.
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1.0 INTRODUCTION 
1.1 Introduction to Salmonella 
1.1.1 Classification of Salmonella 
The genus Salmonella consists of two species: Salmonella enterica and Salmonella 
bongori. S. enterica can be further divided into six different subspecies: S. enterica subsp. 
enterica, S. enterica subsp. arizonae, S. enterica subsp. diarizonae, S. enterica subsp. salamae, 
S. enterica subsp. houtenae and S. enterica subsp. indica 35,65,142. Due to previous naming 
conventions, these subspecies are sometimes referred to as S. enterica subspecies I (enterica), II 
(salamae), IIIa (arizonae), IIIb (diarizonae), IV (houtenae) and VI (indica) 65. Prior to its 
designation as a distinct species of Salmonella, S. bongori was referred to as S. enterica 
subspecies V. These subspecies further contain many different serovars or serotypes of 
Salmonella, such as the S. enterica subsp. enterica serovars Typhimurium, Enteritidis, Typhi and 
Choleraesuis. Almost 2600 serovars of Salmonella have currently been described 40. Of these, 
60% belong to S. enterica subsp. enterica, as do 99% of all Salmonella isolates taken from 
humans and domestic mammals19. Salmonella can also be loosely divided into two groups based 
on the diseases they typically cause in humans: typhoidal and nontyphoidal Salmonella 43. 
Typhoidal Salmonella, such as the S. enterica subsp. enterica serovars Typhi and Paratyphi, 
cause a systemic disease known as typhoid fever characterized by fever, abdominal pain and the 
presence of a rash, while nontyphoidal Salmonella, such as Salmonella enterica subsp. enterica 
serovar Typhimurium (referred to as Salmonella Typhimurium), typically cause a self-limiting 
gastroenteritis 72.  
1.1.2 Disease, pathogenesis and epidemiology of Salmonella infections 
Human infections with nontyphoidal species of Salmonella typically present as self-
limiting gastroenteritis with symptoms of nausea, abdominal pain, diarrhea, vomiting and 
headache 75,78,124. The incubation period before the onset of clinical signs varies depending on the 
individual and the inoculation dose but typically ranges from 6 – 72 hours 75. Systemic infection 
can occur in rare cases leading to complications such as bacteremia, meningitis, encephalitis, 
osteomyelitis and endocarditis 75,78,124. Risk factors for severe disease following infection include 
immunosuppression, recent antibiotic use, HIV infection and both extremes of age 75,124. As most 
nontyphoidal Salmonella (NTS) infections are typically self-limiting, antibiotic therapy is not 
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recommended except in severe cases, and in some cases may even prolong the duration of 
disease and/or shedding of the bacteria 75. Due to the increasing presence of antibiotic-resistant 
isolates of various Salmonella serovars (such as Salmonella Typhimurium) in foodborne 
infections, the avoidance of antibiotic use will likely become even more pronounced in the  
future 111,117. 
Upon encountering a susceptible host, nontyphoidal Salmonella species, like Salmonella 
Typhimurium, begin by colonizing the terminal ileum and colon, causing gastroenteritis 139. 
Using a type III secretion system (T3SS) encoded by the Salmonella pathogenicity island 1 
(SPI1) bacteria are able to penetrate and invade intestinal epithelial cells using various effector 
proteins secreted by the SPI1 T3SS, preferentially targeting M cells 72. Once inside epithelial 
cells Salmonella are able to invade tissue mononuclear cells (i.e. macrophages and dendritic 
cells) and using a second T3SS – encoded by the Salmonella pathogenicity island 2 (SPI2) – they 
sculpt the intracellular environment to their benefit 139. A local inflammatory immune response is 
induced, resulting in large infiltration by polymorphonuclear leukocytes (PMLs) into the 
intestinal lumen resulting in the characteristic intestinal inflammation and diarrhea 72. Infection 
of a healthy individual with nontyphoidal Salmonella typically results in pathology that is limited 
to the intestine, but immunocompromised individuals may experience a systemic disease aided 
by the presence of Salmonella in immune cells and their dissemination throughout the body 72. 
Nontyphoidal Salmonella are a major contributor to foodborne bacterial infections, 
causing an estimated 94 million infections worldwide each year leading to 155,000 deaths 99. In 
the United States, nontyphoidal Salmonella are the leading cause of both hospitalization and 
death by foodborne illness 126,127, and they are estimated to cost the Canadian economy $846 
million each year 143. Foodborne outbreaks of Salmonella are commonly seen and typical sources 
of infection include food products such as beef, chicken, pork, eggs, dairy products and fresh 
produce 111,147. According to a study from the Centers for Disease Control (CDC), the most 
commonly isolated Salmonella serovars in the U.S. in 2009 were Salmonella Enteritidis, 
Salmonella Typhimurium, Salmonella Newport, Salmonella Javiana and Salmonella  
Heidelberg 20. Novel sources of Salmonella infection continue to emerge, likely due to the 
adaptability of Salmonella, their ability to persist for prolonged periods of time in numerous food 
products 111, as well as new trends in how the population is consuming food. The emergence of a 
global marketplace sourcing products from many countries with differing standards of microbial 
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surveillance as well as an increasing population of aging individuals suggests that foodborne 
illnesses will likely remain a significant problem in the future 111. 
1.1.3 Salmonella life style 
Most S. enterica subsp. enterica serovars are believed to have a cyclical lifestyle 
involving both a host-associated, infectious phase and an environment-associated, persistent 
phase 155. The host range for many Salmonella serovars encompasses a large spectrum of animals 
including, but not limited to humans, primates, mice, chickens, pigeons, cows, pigs and  
lizards 21,45. Differences in the specificity of host restriction as well as in disease severity are 
thought to be due to the existence of both a core set of genes shared by most serovars of 
Salmonella (genes related to metabolism, DNA replication, etc.) as well as variable areas of the 
genome related to virulence and the colonization of specific hosts 21,40,45,116. This suggests that an 
individual serovar may be well adapted for the infection of their typical host yet poorly adapted 
for the infection of a sufficiently different host species. Different Salmonella serovars can also be 
classified as host-generalist, host-adapted or host-restricted. Host-adapted and host-restricted 
serovars of Salmonella typically cause invasive diseases and spend the majority of their life 
inside of infected hosts where they have developed specific strategies to evade immune  
detection 147. Host-generalist serovars typically cause gastroenteritis in a broad range of hosts and 
the environment plays a larger role in their life style and transmission 11. This difference in life 
style is thought to be largely due to the loss of genes in host-restricted and –adapted serovars of 
Salmonella, resulting in their increased dependency on their host 11. 
Infected hosts act as reservoirs of Salmonella who then seed the environment with 
bacteria where they persist until they encounter another susceptible host 106. The ability of 
Salmonella cells to persist in the environment for prolonged periods of time increases the 
chances that they will successfully transmit to a new host and continue the infectious cycle 155. 
Studies have shown that an individual strain of Salmonella can be isolated in an area from both 
infected animals themselves as well as from environmental sources nearby (i.e. soil, slurry, 
cages, etc.) even after disinfection, which act as a source of further infection and propagation 5,41. 
Certain Salmonella serovars are also able to persist for periods of several weeks in water sources 
such as ponds, surface water and sewage and these can act as environmental sources of 
contamination as well 18,96. These observations support the idea that the environment and 
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environmental reservoirs play a significant role in the persistent life style of Salmonella. The role 
of biofilms in this persistent phenotype of Salmonella will be explored in a subsequent section. 
1.1.4 Salmonella mouse models  
The majority of information regarding Salmonella pathogenesis and infection comes from 
the use of mouse models 59. In these models, it has been observed that Salmonella invade gut 
epithelial cells, some with a preference for M cells, in the small intestine before entering the gut 
associated lymphoid tissues (GALT) that lie underneath the epithelium 43. From the GALT, 
Salmonella spread systemically throughout the body and enter the spleen and liver, where they 
reside in phagocytic cells, as well as the mesenteric lymph nodes 43. In these models, the murine 
gut has much less inflammation than what is observed in human gastroenteritis 7. Resistance to 
murine Salmonella infection is primarily controlled by the mouse solute carrier family 11α 
member 1 locus (Slc11α1, formerly known as Nramp-1) that aids in acidifying phagosomal 
compartments in macrophages 14. Susceptible Slc11α1- mice, such as C57BL/6 and Balb/c mice, 
are used as an acute infection model of Salmonella infection as they typically succumb to 
infection due to their inability to control Salmonella replication and spread. In a chronic model of 
Salmonella infection, resistant Slc11α1+ mice are used as they are able to control Salmonella 
replication in the spleen and liver, resulting in a sub-acute, persistent and chronic infection that 
can last for a period of months 107. 
To more closely mimic human gastroenteritis, the streptomycin-treatment mouse model 
of Salmonella infection was developed 7. First published in 2003, this model proved to display 
many of the hallmarks of human gastroenteritis in mice: epithelial ulceration, edema, induction 
of intercellular adhesion molecule 1 and a large proliferation of PML/CD18+ cells were all 
observed using this model. The streptomycin model involves treating mice with a single dose of 
the antibiotic streptomycin prior to challenge with Salmonella, which results in a transient 
disruption of the microbiota 136. This leads to high levels of gut colonization in the colon and 
cecum and high levels of intestinal inflammation within the first 24 hours 82. Salmonella blooms 
in the murine gut within 4 – 6 hours post-infection, resulting in high bacterial densities in the 
large intestine and high levels of bacterial shedding in the feces 7. Compared to bovine and 
primate models – the typical models used to study gastroenteritis – there are identical virulence 
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factor requirements in the streptomycin mouse model, suggesting it is a more economical model 
to effectively study the effects of Salmonella-induced gastroenteritis 82. 
1.2 Salmonella biofilms 
1.2.1 Composition of Salmonella biofilms 
A bacterial biofilm is defined as a structured community of bacteria encased in a self-
produced extracellular matrix, typically attached to a biotic or abiotic surface 137. Biofilms 
represent a major and common form of bacterial life in the various natural environments 128. 
Biofilm development is thought to be a sequential process beginning with unaggregated 
planktonic cells which reversibly bind to a surface and form microcolonies of aggregated cells 
followed by the formation of larger, hardier macrocolonies. Mature biofilms are thought to be 
dynamic, multilayered structures where cells are free to disperse back into the environment as 
both planktonic cells or clusters 108,128,159. Salmonella biofilms consist of both protein and 
polysaccharide components linked together in an extracellular matrix, and this matrix mediates 
interactions with the environment surrounding the bacteria 55. The protein components of 
Salmonella biofilms consist largely of curli fimbriae (previously referred to as thin, aggregative 
fimbriae – Tafi) 33,121 and secreted BapA 92, while the polysaccharide components are composed 
mainly of cellulose and an O-antigen capsule 55, with small levels of other polysaccharides such 
as LPS 137. The rdar morphotype (red, dry and rough) has been characterized as one of the major 
biofilm types of Salmonella, and is characterized by its unique colony morphology 151. rdar 
colonies take on a red color when grown in the presence of the dye Congo red due to staining of 
various components of the biofilm extracellular matrix, and deficiencies in the production of 
these components can be observed due to abnormal staining 162. 
The structural components of curli fimbriae are encoded by the csgBAC operon, where 
CsgA is the major structural subunit (csg for curli synthesis genes. agf, for aggregative fimbriae, 
was used previously but csg will be used going forward in this thesis). Research has shown that 
curli fimbriae are involved in the initial attachment phase of biofilm formation where bacteria 
adhere to a surface 6,97, as well as in further interactions with both host and bacterial cells, linking 
cells together in a matrix 154. They have been implicated in the attachment of cells to abiotic 
surfaces and are typically produced only at temperatures below 30° C 123, suggesting they play a 
significant role outside of hosts. BapA is a large protein that is secreted from cells and associates 
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at the cell surface along with other biofilm components 92. It is thought to play a role in the 
physical connections of cells in a biofilm, strengthening and reinforcing the bonds made by the 
other biofilm components 137. It was found that BapA-deficient mutants had reduced invasion of 
epithelial cells as well as reduced colonization of host organs, indicating that it may play a role in 
host cell colonization and invasion, providing a potential link between biofilm formation and 
virulence 92. 
Cellulose biosynthesis is controlled by the bcsABZD and bcsEFG operons and requires 
indirect activation of the trans-membrane protein AdrA (described in Section 1.2.2 below). 
Cellulose is composed of repeating (1➝4)-β-linked D-glucose chains; the chains align to form a 
hydrophobic, inert matrix that, along with curli fimbriae, traps and holds cells together in the 
biofilm 162. This matrix is highly resistant to both strongly acidic and strongly alkaline solutions, 
in agreement with its proposed role in resistance 162. Cellulose is also thought to play a critical 
role in adhesion to external surfaces due to its sticky texture and its ability to facilitate long-
range cell-to-cell interactions 137. The Salmonella O-antigen capsule is structurally very similar to 
the O-antigen component of LPS, with a few substitutions to the side-chains of the 4-sugar 
repeating unit 55. The yihU-yihO and yihVW operons, which code for the production of the O-
antigen capsule, are conserved throughout the Salmonella genus, suggesting they likely play an 
important role in the life cycle of these bacteria 55. The O-antigen capsule is composed of  >2300 
repeat units which is ~100 times greater than that found in the LPS chains of most typical 
Salmonella 55. It is hypothesized to play a role in protecting the biofilm-encased cells against 
desiccation and therefore likely also involved in environmental survival 55. 
1.2.2 Regulation of Salmonella biofilm formation 
Salmonella biofilm formation is regulated by a highly complex regulatory network 
involving many different interconnecting systems 137,150. CsgD is the major transcriptional 
response regulator that regulates the expression of the different structural components of the 
biofilm matrix 54. It has been implicated in the regulation of the csgBAC operon which encodes 
curli fimbriae 160, the bapABCD operon which encodes BapA 92 and the yihU-yihO/yihVW 
operons which encode the Salmonella O-antigen capsule 55. Biosynthesis of cellulose is likewise 
indirectly regulated by the binding of CsgD to adrA; this results in the production of bis-(3’–5’)-
cyclic dimeric guanosine monophosphate (c-di-GMP), an important secondary messenger, which 
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allosterically activates the enzymes BcsA and BcsB 160. Recently, a CsgD-independent pathway 
of cellulose production was identified, suggesting that other regulatory methods exist separate 
from CsgD 129. Mutants in csgD lack multicellular behavior and do not produce the major biofilm 
components 137. 
The regulation of CsgD itself is also complex. One method of its regulation is through the 
activity of 6 different diguanylate cyclases and phosphodiesterases which regulate the 
intracellular pool of c-di-GMP 160. There are also many different environmental signals that 
regulate its transcription: temperature, osmolarity, nutrient levels, iron concentration, pH and 
oxygen levels have all been shown to influence the transcription of csgD 54. Typically, stationary 
growth in conditions of high cell densities and low nutrients activate the expression of csgD 137. 
Many different trans-acting regulators have been implicated as well: H-NS, OmpR, IHF, CpxR 
and MlrA have all been shown to affect the expression of csgD 137. The variety of inputs that 
regulate the expression of csgD allow its expression to be fine-tuned in response to varying 
environmental conditions, increasing the sensitivity of biofilm formation as a physiological 
response. A study found that csgD expression was bimodal in a population of cells; cells either 
had high expression of csgD or had its expression turned off, with little intermediate expression 
observed 60. High expression of csgD was associated with the population of aggregated cells 
while low expression of csgD was associated with planktonic, single cells. It has been 
hypothesized that the bistable expression of csgD exists in order to maximize the survival 
potential of a population of cells under changing environmental conditions, ensuring that a subset 
of the population survives regardless of the conditions encountered 137. 
RpoS (σS), encoded by rpoS, is another major regulator of biofilm formation. As a sigma 
factor, it regulates the transcription of many genes that are involved in the stress response and 
environmental survival, both situations where biofilm formation could occur. It has been shown 
that over 25% of the RpoS regulon was upregulated in biofilm-associated cells, as well as that 
wild-type Salmonella had 3 times the transcription levels of RpoS as a csgD mutant, which was 
unable to form biofilms 70,150. RpoS has also been implicated in the regulation of csgD, adrA and 
the csgBAC operon, suggesting it plays a significant role in overall biofilm regulation 137. The 
PhoPQ two-component regulatory system has also been shown to regulate biofilm formation by 
repressing their formation, possibly through indirect regulation of RpoS levels in a cell. PhoP has 
been shown to both stabilize RpoS through the activity of IraP, as well as to enhance its 
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degradation through the activation of RstA 25,144. This suggests that PhoPQ is involved in the 
tight regulation of RpoS levels in a cell, which impact the ability of Salmonella to form biofilms. 
Overall the high level of regulation of biofilm formation in Salmonella underlines both its 
importance as well as the high energy costs of producing a biofilm; the process of producing the 
components of the biofilm matrix is a costly endeavor, and would not be started until a cell 
received the input from many different systems. 
1.2.3 Survival advantages of biofilm formation 
Aggregation of Salmonella cells via the rdar morphotype was shown to provide a 
virulence disadvantage against wild-type cells 151, suggesting that aggregation, and therefore 
biofilm formation, has a function separate from Salmonella virulence. The rdar morphotype itself 
is generally associated with curli fimbriae production, cellular aggregation and biofilm  
formation 32,153. Supporting its role in non-host survival and environmental persistence, it was 
found that the genes involved in curli synthesis (an important indicator of rdar morphology) 
remain inactive inside of a mouse and are expressed only after being shed into the external 
environment 151. The rdar morphotype was also found to be highly conserved throughout 
Salmonella 153, supporting the idea that it plays a role in a significant portion of the Salmonella 
life style. 
It has been shown that rdar-positive cells, when compared to mutants in csgD (biofilm 
transcriptional regulator), csgA (curli fimbriae) and bcsA (cellulose production), had increased 
resistance to prolonged periods of desiccation in the absence of nutrients 152. The majority of 
cells in rdar colonies grown on agar remained alive after a period of nearly 2 months and 
colonies that had been peeled off of agar and desiccated for up to 9 months in plastic wells 
continued to harbor viable cells. The mutant strains in question all had reduced survival, 
indicating that curli fimbriae and cellulose both played a role in the long-term survival of these 
cells. Cellulose was also observed to play a role in protecting rdar colonies against sodium 
hypochlorite (bleach), a common disinfectant, confirming earlier reports of the vital role of 
cellulose in resistance to sodium hypochlorite 133. A study looking at the survival benefits of the 
O-antigen capsule in similar conditions found that it was highly involved in resistance to 
desiccation 55. O-antigen capsule mutants (∆yihO, ∆yihQ and ∆Pyih) had significant reductions in 
their survival after desiccation to levels similar to that of the ∆csgD mutant, which had the 
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lowest survival observed in other studies 152. In a later study it was found that rdar cells had 
upregulated many genes involved in osmoprotection, suggesting a mechanism through which 
rdar cells could resist desiccation 150. 
Various other studies have shown that Salmonella biofilms impart resistance to many 
disinfectants, sanitizers and antibiotics. A study comparing the survival of biofilm-associated and 
planktonic cells of Salmonella Weltevreven found that biofilm cells resisted both chlorine and 
iodine at much higher concentrations than planktonic cells 80. Biofilm cells required both 
increased contact time as well as higher concentrations than planktonic cells to be completely 
eradicated. A similar study found that 2-day old biofilms had increased resistance to three 
different disinfectants when compared to planktonic cells 109. Biofilms of the S. enterica serovars 
Senftenberg and Agona were found to be resistant to disinfectants based on cationic tensides, 
glutaraldehyde and hypochlorite (bleach), while ethanol-based disinfectants appeared to be quite 
effective. They also found that surface-dried Salmonella retained many resistance properties 
against these disinfectants, suggesting that desiccation-resistant cells are resistant to these 
disinfectants as well. Various antibiotics have also been tested to demonstrate the resistance of 
biofilm-associated cells compared to planktonic cells. In one study, planktonic cells were 
susceptible to most antibiotics tested (5 of 7) while biofilm-associated cells were resistant to all 
antibiotics tested except enrofloxacin and ampicillin 112. In another study, biofilm-associated 
Salmonella were found to have almost 2000-times the resistance to ciprofloxacin than planktonic 
cells 138. This is especially of interest because ciprofloxacin and other third-generation 
cephalosporins are regularly used to treat nontyphoidal Salmonella infections 137; if biofilm-
associated cells are involved in human infections, this could reduce the efficacy of treatment in 
these patients. 
1.3 Bacterial transmission 
1.3.1 Role of transmission in the bacterial life cycle 
Transmission plays a large role in the lifestyle and fitness of bacterial species and is both 
a vital and required component in ensuring their maintenance in a host population 15,94. The 
cyclical nature of transmission suggests that it encompasses distinct stages of host infection and 
colonization, the exit from a host into the environment as well as movement from the 
environment into a subsequent host 94,106. While both host infection and colonization are 
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important in the overall cycle of transmission, they remain well-represented areas of Salmonella 
research; the factors involved in inducing the exit from a host into the environment as well as in 
facilitating the movement into a new host remain poorly understood, and are the focus of this 
thesis. As mentioned previously, many Salmonella species have a lifestyle that involves a 
significant environmental stage in between host colonization events that can last for prolonged 
period of time 155. This is not uncommon for pathogens: the transmission of many pathogens 
from host-to-host involves the environment as a tool to gain access to subsequent hosts 17. The 
ability of bacteria like Salmonella to replicate outside of their primary host – such as in the 
external environment – increases their odds of transmission by allowing them to remain in the 
environment for extended periods of time until a susceptible host can be found 3, 114. The ability 
to transmit from host to host also increases the overall fitness of bacteria, especially when 
conditions become unsuitable for continued persistence in the current host 3.  
The process of transmission must also exist as a balance between the ability to transmit to 
subsequent hosts and the appropriate level of virulence in the current host. If the primary 
transmission event occurs after a large amount of damage has been done to the infected host it 
will be unlikely to support subsequent transmission events 51, reducing the total transmission 
potential of each host. This would not be to the benefit of the bacteria as each host would have a 
limited number of opportunities where transmission could occur due to the significant damage 
each event caused. A general trade-off model has previously been proposed, suggesting that any 
pathogen must make trade-offs between transmission and host survival 44. Low levels of 
colonization typically result in reduced virulence and prolonged host survival but low pathogen 
transmission. High levels of reproduction in the host result in increased virulence and shorter 
periods of host survival but bring the benefit of high levels of transmission potential. Ideally, a 
balance would be found with optimal survival for both the host and pathogen. Alternatively, it 
could be said that the high extra-host stability of bacteria like Salmonella decreases the fitness 
costs of virulence in this situation; it allows the bacteria an alternate strategy of continued 
persistence regardless of whether their hosts survives 148. Regardless, this suggests that bacterial 
persistence and transmission have evolved through a balance of selection for both bacterial and 
host interests, resulting in overall homeostasis between the propagation of bacteria and their 
maintenance in a host 15.  
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Bacterial transmission is a poorly understood topic at present. Many host and bacterial 
determinants involved in the process that facilitate host-to-host transmission remain unknown 
while the topic continues to be poorly represented in microbial research 57,94. It is estimated that 
most Salmonella enterica subsp. enterica serovars have significant portions of the genes in their 
genomes (20 – 30%) with unknown functions 71. It is possible – even probable – that a large 
portion of these genes have functions in environmental persistence and transmission and are not 
involved in virulence. The time between host colonization events is a key period where 
interventions could be directed in order to reduce the transmission of pathogens like Salmonella 
within the human population, and in turn reduce the adverse impact that these bacteria have on 
the healthcare system. This is especially important for pathogens where pharmacological 
interventions have limited use 16, and these types of targeted interventions have been theorized to 
result in substantial reductions in the rates of transmission and infection seen in a heterogenetic 
population 158. In order to effectively develop these kinds of interventions against Salmonella, its 
interactions with both the external and host environments must be well-characterized 24 and key 
transmission routes must be identified 57. Interventions must also be directed against all aspects 
of a pathogen’s transmission; for example, poor sanitation procedures result in the contamination 
of water supplies, which may then contaminate food sources and these food sources enter society 
as contaminated food products that negatively impact the healthcare system 46. Interventions 
would need to touch on proper sanitation procedures, the monitoring and handling of livestock 
and the testing of food before it enters the human environment among all other potential aspects. 
As both population movement and growth increase in the near future the horizontal transmission 
of pathogens is likely to become a greater problem 15, and such interventions will likely become 
necessary to prevent the mass dissemination of disease. 
1.3.2 Epidemiological studies examining Salmonella outbreaks and transmission 
A large majority of the research directed at Salmonella transmission exists as 
epidemiological studies examining the sources of outbreaks. These studies are largely 
retrospective but remain useful in identifying the potential sources of Salmonella infection and 
the reasons that these outbreaks occurred. In general, these epidemiological studies examine the 
potential sources of Salmonella infection or the risk factors that predispose individuals to 
infection with Salmonella 95. While useful at determining such potential sources of Salmonella 
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infection, the length of time they take to produce actionable results often results in a delay of 
immediate aid (i.e. product recalls). By the time the source has been identified it is possible that 
many contaminated products have already been consumed, resulting in lowered efficacy of 
potential aid. 
Contaminated water can be an important source of Salmonella outbreaks; Salmonella 
species were the causative agents of 19% of all drinking water-associated outbreaks in the United 
States from 1971 – 2006 34. The source of a 2008 outbreak of Salmonella Typhimurium in the 
town of Alamosa, Colorado was traced to the local water supply 1. During the outbreak 434 cases 
of Salmonella infection were reported, 124 of which were laboratory-confirmed, 20 which 
resulted in hospitalization and 1 which resulted in death. The majority of cases were thought to 
be unreported with an estimated total of 1,300 infections (15 – 20% of the town’s population). 
The source of contamination was determined to be animal fecal contamination of a supply tank 
that was part of the water supply; due to the town’s water being unchlorinated, this 
contamination spread to the population. A study looking at a small 2008 outbreak of Salmonella 
serotype I 4,[5], 12:i:- (a serotype similar to Typhimurium) in a rural town in Texas had similar 
findings 90. Contamination at a water source was hypothesized to be the cause of infection, likely 
from animals or a nearby septic tank. These and similar reports highlight the importance of water 
as a source of mass Salmonella transmission as well as the potential for animal shedding as a 
contaminant, suggesting that interventions directed at these sources would be largely beneficial. 
Contaminated water sources have also been implicated in Salmonella outbreaks 
associated with the consumption of contaminated fruit and vegetables. A 2008 study examining a 
Salmonella Newport outbreak in 2005 found that the source was tomatoes from Virginia that 
were contaminated from pond water used to irrigate the tomato fields 62. This strain caused 72 
laboratory-confirmed cases of Salmonella infection across 16 states with an estimated 2,500 total 
cases. Salmonella was detected in a nearby pond that was, in some cases, sprayed onto tomato 
plants. Generally, tomato-related Salmonella outbreaks are highly geographically dispersed, 
which suggests that the initial point of contamination is generally the farm or distribution facility 
rather than the point of sale to a consumer 62. This implies that the most impactful location for 
direct interventions would be at the farm or distribution level. Similar to the previous findings, a 
2009 study looking at an outbreak of Salmonella Saintpaul in Australia found that cantaloupe 
were the most likely source of infection 110. Although they were unable to determine the exact 
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source, a few farms examined during the trace-back investigation had positive environmental 
contamination for Salmonella species. A previous study had shown that Salmonella could be 
recovered from cantaloupe for up to 21 days if stored at 4° C and up to 14 days if stored at 20° C, 
suggesting that these bacteria were able to persist for prolonged periods of time on the surface of 
the fruit 119. Cases such as these suggest that the contamination of fruits and vegetables with 
Salmonella commonly happens due to environmental contamination at the farm or distribution 
level. 
A 2009 study examined the risk factors in children involved with bacterial reportable 
enteric infections (REI-B), specifically those with Salmonella, Campylobacter, Shigella and E. 
coli O157 infections 39. Risk factors associated with Salmonella infection included the 
consumption of raw pork and shrimp, raw sprouts and bagged lettuce/spinach, the presence and 
use of a private well or septic system at home and the use of natural water sources for recreation 
use. Another study examining risk factors for developing Salmonella bacteremia in children 
determined that, along with previous cases of gastroenteritis and antibiotic exposure, patients 
were more likely to develop bacteremia during the summer as compared to the colder seasons 66. 
A Canadian study examining the risk factors of Salmonella Enteritidis infection from 2007 – 
2009 found that being between the ages of 0 – 4, travelling internationally as well as the spring 
months (March – May) were associated with higher risk of Salmonella infection 146. Along with 
the typical risk factors of consuming contaminated food sources, these findings suggest that non-
food sources also play an important role in the transmission of Salmonella. 
1.3.3 Environmental reservoirs of Salmonella 
Environmental reservoirs play a large role in the survival and persistence of Salmonella 
species, as well as aiding in their perpetuation. As discussed above, Salmonella are frequently 
detected in environmental water samples. Salmonella species have been isolated from diverse 
water sources all over the world: from rivers in Canada 79 and the U.S. 103, surface and potable 
water in South Asia 81, rural irrigation water in Alberta 52, drinking water in New Zealand 141 and 
many other sources. The ubiquity and persistence of these bacteria underlines the number of 
potential sources of contamination and entrance into the human population, through other vectors 
as well as food products. As mentioned previously, contaminated water sources are thought to be 
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a significant contributor to the contamination of fresh produce with Salmonella and other 
bacteria 10, highlighting another area where the indirect impact of water can be seen. 
Rodents are also believed to be a natural vector of Salmonella that play a role in their 
transmission and persistence. Although food production animals are the main source of direct 
human infection, rodents are thought to act as vectors that help maintain Salmonella in an 
agricultural environment 74. This is especially of concern in areas housing food production 
animals, such as farms, due to their direct link into human consumption. Studies have shown that 
the risk of Salmonella persisting on a farm after decontamination increased with the presence of 
rodents, suggesting they may act as a reservoir for subsequent bacterial seeding 48,122. It has also 
been suggested that rodents act to amplify the presence of Salmonella on farms. In one study of 
poultry farms rodents were found to have three times the infection levels with Salmonella 
Enteritidis than the surrounding environment, suggesting the rodents act to amplify the levels of 
Salmonella present in a given environment 73. Due to the high density of rodents on some farms 
and their tendency to cluster together, this allows for rapid horizontal transmission of Salmonella 
throughout the population, reinforcing its maintenance. It also allows rodents to act as a 
persistent source of Salmonella, where they constantly reintroduce bacteria into the environment 
and subsequently re-infect other food-producing animals 102,131. 
Livestock are another reservoir of Salmonella that frequently enter the human 
environment. Chickens, pigs and cows are all known to be potential carriers of Salmonella and 
represent a major route of human infection 57. In chickens, colonization with Salmonella can 
remain subclinical in many animals, making it difficult to detect in the food production chain 
prior to its consumption 8. One study found that the overall prevalence of Salmonella on 
conventional broiler poultry farms was approximately 28% 2, and the consumption of chicken 
remains a risk factor for salmonellosis 100. Salmonella Choleraesuis has been shown to spread 
throughout pig populations rapdily and remains infective even after 2 – 4 months in desiccated 
feces 61. Similarly to poultry, Salmonella infections in pigs often remain asymptomatic and result 
in high levels of shedding in a significant proportion of the population 88. A study looking at 
Salmonella rates on swine farms in the U.S. found that over 50% of farms tested positive for the 
presence of Salmonella 69. Numerous Salmonella serovars are frequently isolated from cattle 
farms, with some serovars such as Salmonella Kentucky having a prevalence of up to 97% on 
Salmonella-positive farms 68.  Other serovars, such as Salmonella Cerro, were shown to persist 
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subclinically in cattle herds for periods of up to 3 years 145. The high shedding and persistence 
levels as well as the ability of Salmonella to colonize production animals at subclinical levels 
increases the presence of Salmonella on livestock farms, resulting in its frequent transmission to 
humans. 
1.3.4 Existing models to study bacterial transmission 
The current transmission models for Salmonella typically employ mouse models of 
chronic infections (i.e. Slc11α1+ mice). The most prominent model, published in 2008, 
demonstrated transmission using a natural model of Salmonella persistent (i.e. chronic) infection 
in 129X1/SvJ resistant mice 94. Mice infected with Salmonella in this model become chronically 
infected for 30 – 40 days post-infection and persistently shed bacteria in their feces. To study 
transmission, four mice were challenged with Salmonella Typhimurium and then mingled with 
one uninfected mouse 5 days post-infection for a period of 28 days. The uninfected mice began 
shedding Salmonella in their feces 1 – 2 days post-mingling and the shedding levels, fecal anti-
Salmonella IgA levels, serum anti-Salmonella IgG levels and colonization levels were all 
indistinguishable from the initially challenged mice at the conclusion of the experiment, 
suggesting that infected mice were rapidly able to transmit infection to naive mice. The authors 
noted that transmission was highly efficient and that most transmission occurred from a small 
subset of the population (<30%) termed supershedders that were shedding ≥108 CFU/g feces of 
Salmonella and were able to transmit infection to 100% of their cage mates. The low and 
moderate shedders shed Salmonella at levels of  <108 CFU/g feces and had no observable 
transmission even after co-housing for 28 days. Of note, after treatment with streptomycin all 
mice were converted to supershedders, underlining the importance of the resident microbiota in 
preventing the supershedder phenotype and high levels of transmission. While useful, this model 
had no reliable method of determining which mice became infected until the conclusion of the 
experiment due to the sub-acute nature of the chronically infected mice (i.e. there were no visible 
symptoms); animals had to be euthanized to determine if transmission had occurred. The large 
majority of the population (>75%) were poor reservoirs of infection; a small subset of mice were 
responsible for the majority of the transmission observed, meaning that large groups of mice 
would be required for any large-scale transmission experiments in order to ensure observable 
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transmission. There remains a niche for alternate transmission models to decipher further aspects 
of Salmonella transmission. 
There have been other preliminary studies examining the transmission of Salmonella in 
other species, though not in completely characterized models. A 1994 study in swine examined 
the rate of transmission from infected pigs to Salmonella-free pigs when co-mingled in the same 
enclosure 49. Eight infected pigs were co-mingled with nine uninfected pigs for 21 days; prior to 
co-mingling the two groups were housed in separate facilities. None of the uninfected pigs 
became symptomatic during the course of the experiment and only one of these pigs tested 
positive in both rectal and tonsil swabs for Salmonella. Some uninfected pigs did have detectable 
Salmonella in their cecum (6), ileum (4) or ileocolic lymph node (8), suggesting that although no 
pigs had overt signs of disease, sub-acute transmission had occurred. A 2006 study examined the 
transmission of antibiotic-resistant or -susceptible isolates of Salmonella Typhimurium in 
chickens 8. Each cage contained two seeder chickens that were challenged with Salmonella and 
10 uninfected chickens. Half of the cages were challenged with an antibiotic-resistant strain of 
Salmonella and half with an antibiotic-susceptible strain. Half of the cages also had their water 
supplies supplemented with chlortetracycline. In cages challenged with the resistant strain and 
supplemented with chlortetracycline there was a 90% transmission rate from seeder chickens to 
naive chickens. In the same groups without chlortetracycline the transmission rate dropped to 
60%, suggesting the antibiotic treatment increased the transmission efficiency of the resistant 
strain. The chickens treated with chlortetracycline also had higher levels of bacteria in the organs 
sampled which may have been responsible for the increased transmission. In cages challenged 
with the susceptible strain and either supplemented with chlortetracycline or not, the 
transmission rates were 95% and 90%, respectively; there was no significant difference between 
these two groups. Currently, there are no transmission models that facilitate the study of specific 
genetic factors in the transmission process of Salmonella and the role they play in transmission.  
Transmission studies also exist for bacterial species other than Salmonella. A 2012 study 
examined the role of spo0A in Clostridium difficile in persistence and transmission using a 
mouse model 38. This work was done after the construction of a generalized model to study the 
spore-mediated transmission of C. difficile in mice 93. Donor C57BL/6 mice were challenged 
with C. difficile and then mingled with uninfected mice treated with clindamycin under different 
conditions. Donor mice challenged with wild-type C. difficile and mingled for 1 hour resulted in 
  17  
100% transmission, while donor mice challenged with the ∆spo0A and then mingled resulted in 
20 – 40% transmission, depending on the strain. When the same experiments were done with a 
porous wall separating the donor and naive mice – to prevent coprophagy but allow contact – 
wild-type C. difficile still transmitted at 100% efficiency while the mutant strains did not have 
detectable transmission. In the same experiment done with a double porous wall – to prevent 
both coprophagy and contact but allow airborne transmission – wild-type C. difficile transmitted 
with 60% efficiency while the mutants again failed to transmit. Finally, to mimic environmental 
transmission donor mice were placed in cages for 1 hour and then both mice and feces were 
removed. The cages were left in a sterile environment for 16 hours and then naive mice were 
placed inside. Wild-type C. difficile transmitted at 100% efficiency while the mutants again 
failed to transmit. These results indicated that spo0A was required for efficient host-to-host 
transmission, and this model allowed for the effective assignment of function to the gene spo0A 
in the transmission and persistence process in C. difficile. 
A 2015 study examining the transmission of Staphylococcus aureus following bacteremia 
determined the impact that a selection of genetic regulatory systems had on transmission 85. 
Infected mice were injected intravenously (i.v.) with S. aureus and then cohoused with naive 
mice for the duration of the experiment. They observed that naive mice became infected with S. 
aureus after co-housing, as demonstrated by the fecal shedding levels in naive mice matching 
those of the i.v.-challenged mice. This suggested that S. aureus could be transmitted to naive 
mice through the fecal-oral route after a period of bacteremia in the original host. ∆sae, ∆agr and 
∆sae∆agr mutants were compared to the wild-type, and it was observed that naive mice caged 
with the double mutant had significantly lower amounts of bacteria in their feces, presumably 
due to reduced transmission. This suggested that the sae and agr regulatory systems, involved in 
the regulation of many virulence factors, also played a role in host-to-host transmission in S. 
aureus. Finally, they determined that antibiotic-resistant strains of S. aureus were preferentially 
transmitted to naive hosts. This model, while able to qualitatively compare different strains in 
their transmission, relied on the detection of S. aureus in the feces of naive mice to measure 
transmission. An ideal model would allow for a more accurate and quantitative measurements of 
transmission to naive mice. 
Other transmission experiments exist as smaller aspects of larger studies. A study 
examining the gastrointestinal colonization of Pseudomonas aeruginosa in mice housed 1 
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infected mouse with 3 uninfected, antibiotic-treated mice and found that there was efficient 
transmission of disease without a contaminated water source. This suggested a role of the fecal-
oral route in the transmission of P. aeruginosa 83. In a study examining lipid modifications of 
ArnT in Bordetella bronchiseptica the transmission efficiency of a ∆arnT mutant was compared 
to the wild-type 120. A mouse challenged with wild-type B. bronchiseptica and then housed with 
2 – 3 naive mice for 21 days transmitted with >80% efficiency to secondary mice. The ∆arnT 
mutant did not transmit to any secondary mice, suggesting that ArnT plays a role in host-to-host 
transmission. Since these studies touched on small aspects of transmission, more comprehensive 
studies would be required to determine the overall requirements and determinants of 
transmission in bacteria. 
1.4 Genetic manipulation of S. enterica chromosomal DNA 
1.4.1 Tn7 transposition 
Transposons are transposable genetic elements 115 that are able to mobilize throughout the 
genome using specialized recombinases – known as transposases – that are typically self-
encoded 12. Generally, transposons exist as mobile elements that, while typically bringing no 
benefit to the host, could potentially cause lethal mutations. That they remain so common in 
nature organisms suggests that they are particularly well suited for rapid dissemination 
throughout the genomes of many different organisms. The bacterial Tn7 transposon is a 
particularly sophisticated example and has many unique and beneficial features. The Tn7 system 
has two main mechanisms for transposition. One method results in highly specific, directed 
transposition into a specific site in the bacterial chromosome – the attTn7 site – while the other 
preferentially targets conjugative plasmids 115. Of particular interest is the chromosomally 
targeted method, as it ensures that transposition can occur without having negative fitness 
impacts on the host bacteria due to its site-specific nature. 
The Tn7 transposon itself is flanked by the Tn7L (150 bp) and Tn7R (90 bp) regions 
which contain transposase-binding sequences, allowing for precise binding of the transposase 
and subsequent transposition 115. DNA contained between these two sequences is excised and 
integrated into the transposition site using the specialized recombinase that is self-encoded by the 
transposition operon. Insertion of the transposon is orientation specific due to the asymmetric 
sequences of both the Tn7L and Tn7R ends, as well as the function of the Tn7 system itself, 
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through TnsAB 28. The transposon contains all the necessary components for transposition: 
namely, the tnsABCDE genes. Transposition with Tn7 minimally requires the tnsABCDE operon 
(only one site selector is required) and the two Tn7 flanking sequences, Tn7L and Tn7R 26. The 
Tn7 transposon system also appears to have a broad host range and is able to function effectively 
in many different bacterial species 101. Using these beneficial elements different Tn7 systems 
have been developed that take advantage of the different aspects of the bacterial Tn7 
transposition system. 
TnsA and TnsB together form the heteromeric Tn7 transposase utilized by the system. 
The transposase introduces double-strand breaks at either end of the transposon, then excises and 
integrates the DNA at the attTn7 site 12. TnsA mediates 5’ strand breaking while TnsB mediates 
both 3’ strand breaking and joining 125. TnsD and E are alternative site selectors that direct the 
transposase to a particular insertion site, depending on which is active, by binding DNA. TnsD is 
a sequence-specific DNA binding protein that directs transposition to the attTn7 site – a 
chromosomal region found downstream of the glmS gene in many bacteria 4. The amino acid 
sequence of the recognition site in glmS was almost 100% conserved in 6 representative 
organisms that were examined (E. coli, Rhisobium leguminsarum, Bacillus subtilus, Candida 
albicans, Caenorhabditus elegans and Homo sapiens) making it an ideal candidate for such strict 
recognition 104,105. While the recognition site is in the 3’ end of the glmS gene, insertion occurs 
downstream of the gene itself; insertion of genetic material at this site has not been found to 
result in any fitness defects to the bacteria itself 115. TnsE preferentially directs transposition into 
conjugative plasmids, though the particular insertion regions have no recognizable DNA 
similarity 156. It is hypothesized that TnsE directs the transposase to regions of DNA structure, 
such as the β clamp of replicating DNA 22. TnsC is an ATP-dependent DNA binding protein that 
acts as a regulator of Tn7 transposition by bringing together the transposase (TnsAB) and the site 
selector (TnsD or TnsE); it activates the transposase when in contact with both the transposase 
itself (through TnsB) as well as the site selector 27. 
1.4.2 Tn7-based transposition and cloning systems 
Due to the ease-of-use, specificity, efficiency and broad host range of Tn7 transposition 
many different cloning systems have been established to take advantage of transposition. These 
systems all utilize the Tn7 system as a mechanism to introduce foreign DNA into the 
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chromosome in a very efficient and site-specific manner. Chromosomal insertion has numerous 
advantages over typical plasmid-based systems. Chromosomal DNA is inherently more stable 
than extra-genomic DNA 101; this heightened stability, along with the systems that monitor the 
integrity of chromosomal DNA 161, ensures that the inserted DNA persists and is not lost during 
subsequent replication and division, as plasmids can be 101. Using plasmid-based reporter 
constructs typically results in a significant proportion of cells in the population experiencing 
plasmid loss, removing them from the pool of reporters 151. Chromosomal insertion also results in 
expression levels more closely resembling physiological levels, allowing for a better 
approximation of function101. Chromosomally integrated constructs also remove the need for 
antibiotic selection, which would typically be required for the maintenance of plasmids but is not 
always desired (i.e. introducing bacteria into the environment or into human patients) 101. It has 
also been shown that the presence of cloning vectors in a cell can alter the virulence of certain 
bacteria, such as Salmonella 89. Finally, the site-specific nature of Tn7-based insertion results in 
repeatable and easily comparable chromosomal insertion. This allows the same construct to be 
inserted in different mutants, allowing for effective comparisons of expression dynamics. These 
are some of the reasons that chromosomal insertion systems are desired for cloning systems, and 
in particular why Tn7-based systems have become popular in recent years. 
In 2005, a system was published that utilized the power of Tn7 transposition to develop a 
broad-based cloning and expression system 26. It used both pUC18T-based and pUC18R6K-
based plasmids to design suicide delivery vectors that would allow the delivery of a construct 
into a cell that could then be targeted for insertion into the chromosome by the Tn7 transposition 
machinery. Main features of the plasmid were either ColEI (pUC18T) or R6K (pUC18R6K) 
origins of replication to allow the plasmids to function as suicide vectors in any non-
Enterobacteriaceae (pUC18T) or in any strain not containing the pir gene required for 
replication (pUC18R6K). They also contained the bla gene encoding β-lactamase to allow for 
antibiotic selection. Each plasmid then contained a multiple cloning site (MCS) flanked by the 
Tn7L and Tn7R sites; this allowed the desired construct to be easily cloned into the MCS and be 
targeted for chromosomal insertion. A second, helper plasmid – pTNS1/2 – containing the genes 
encoding the transposition machinery (tnsABCD) was used to mobilize the construct contained 
between the two Tn7 sites into the chromosome of the desired strain. Using this system, the 
authors demonstrated efficient transposition in P. aeruginosa as well as demonstrating that 
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transposition occurred downstream of glmS at the attTn7 site 100% of the time in Pseudomonas 
putida, a species that was not known to have a unique transposition site, when using the pTNS1 
helper plasmid. To demonstrate the universal utility of the system they also demonstrated it 
working in Yersinia pestis, a species with no known site-specific integration cloning systems, as 
well as in Burkholderia thailandensis, a species whose complete genome was unknown at the 
time. Finally, they constructed P. aeruginosa strains containing chromosomally located 
expression systems to demonstrate the uses of the Tn7-based cloning system. 
This mini-Tn7 system has been modified in different ways since its publication. Recently, 
a group published a modified system by adding a PBAD promoter and araC gene between the 
Tn7L and Tn7R sites to control the expression of the construct once inserted into the 
chromosome 37. This new plasmid – called pTJ1 – contains the trimethoprim-resistance encoding 
dhfRII gene as well. Using this new delivery vector, as well as the updated helper plasmid 
pTNS3, the authors demonstrated the function of the system by efficiently cloning their gene of 
interest into both P. aeruginosa and Burkholderia cepacia complex (BCC) species. The same 
group later published a separate modification of the mini-Tn7 system containing the luxCDABE 
operon contained between the Tn7L and Tn7R sites, whose expression was driven by the 
constitutive P1 integron promoter 36. The promoter region also allowed for the easy removal and 
insertion of any promoter of choice to facilitate promoter-expression studies. The authors 
demonstrated the utility of the promoter-luciferase constructs, both in vitro and in vivo using 
mice monitored on a bioluminescent imager. 
A modified Tn7 system was published in 2006 which combined the helper and delivery 
vectors into a single plasmid – pGRG25 101. This plasmid contained a MCS flanked by the Tn7L 
and Tn7R sites to allow for simple ligation of the desired construct. The tnsABCD operon was 
contained on the same plasmid outside of the Tn7L and Tn7R ends to ensure it wasn’t excised 
along with the desired construct. Expression of the tnsABCD operon was driven by a PBAD 
promoter to allow for controlled expression of the transposition machinery; the araC gene was 
also contained on the plasmid, enabling arabinose-inducible expression of the tns operon. The 
vector had a temperature-sensitive pSC101 origin of replication enabling it to be cured from the 
recipient cells after transposition, as well as the β-lactamase-encoding bla gene for antibiotic 
selection. Using this system the authors confirmed that all cells contained the transgene at the 
attTn7 site and that transposition occurred in 79% of cells that were tested. They tested the 
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system in various E. coli isolates and indicated that the system would work in any bacterium that 
supports the replication of pSC101-origin plasmids (E. coli, Salmonella and Shigella species); 
they also hypothesized that altering the origin of replication should result in effective function 
outside of the Enterobacteriaceae. This system had the benefit of requiring only a single 
plasmid, reducing the necessary work, as well as being claimed to be highly efficient. Due to this 
efficiency the authors claimed that drug selection was not necessary to obtain successful 
transposition. 
The pGRG25 system was later modified by a subsequent group to contain the bacterial 
luciferase operon – luxCDABE – in the MCS, resulting in the plasmid pBEN276 77. The 
expression of the lux operon was driven by the E. coli frr promoter, which is a housekeeping 
gene encoding a ribosome recycling factor; this resulted in constitutive expression of the lux 
operon in subsequent reporter strains generated using this system. The indicated use for this 
system was to easily generate luciferase reporters in any strain of interest. They characterized the 
luciferase expression of reporters they generated and determined that the luciferase construct was 
stable in the chromosome for the tested period of time. Luciferase expression was also tested and 
found to be consistent over a range of temperatures including 25° C and 37° C, but not 4° C. 
Overall, this system demonstrated a method to efficiently generate luciferase reporters using a 
modified single-plasmid system. 
1.5 In vivo bioluminescent imaging technologies 
1.5.1 Overview of Photorhabdus luminescens bacterial luciferase 
Bacterial luciferases are the most widely distributed bioluminescence systems in nature 
and have long been of interest to researchers 31. Bacteria that produce bioluminescence are 
largely found in three genera: Vibrio, Photobacterium and Photorhabdus 31. The genes involved 
in bacterial luminescence are encoded by the luxCDABE operon. The luciferase reaction is 
catalyzed through the actions of both LuxA and LuxB, which form the 78 kD luciferase enzyme 
and together oxidize a long-chain fatty aldehyde in the presence of both oxygen and riboflavin 
phosphate (FMNH2) to generate light 31,140. The remaining members of the lux operon – LuxC, 
LuxD and LuxE – are involved in the regeneration of the long-chain fatty aldehyde required for 
the production of light. If supplied with oxygen, FMNH2 and a long-chain fatty aldehyde the 
luciferase enzymes will autonomously generate light mainly at 490 nm, along with a secondary 
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peak at 590 nm 140. Bioluminescence can be detected using a specialized apparatus, such as a 
luminometer. In the mid-1980’s, the full luciferase gene cassette – the luxCDABE operon – was 
successfully cloned and expressed in E. coli 9. Due to the current ease of use (i.e. not requiring 
the addition of exogenous substrates) bacterial luciferase is an increasingly popular system for 
many scientific applications 29,63.  
1.5.2 Applications of the bacterial luciferase reporter genes 
Over the past few decades bacterial luciferase has been utilized in many different fields 
as a tool to visualize diverse biological processes 63. LuxAB makes a notable reporter for 
biological systems due to the quick response time of its expression to variable conditions, 
allowing it to function as a real-time measurement of activity. Simple, unobtrusive detection 
methods also allow biological systems to be examined without disrupting their function, 
allowing for the continued observation of the same sample over a time-course 29. These benefits 
have lead to its use in many different applications. A study in 1985 first demonstrated the use of 
the lux operon as a way to measure gene expression 47. The lux operon was inserted into a 
promoterless mini-Mu transposon and E. coli cells were mutagenized using this mini-Mulux 
transposon. Target gene interruption resulted in the expression of the lux genes as a measure of 
target gene activity, with simple and sensitive detection of light as an indicator. A few years 
later, in 1989, E. coli cells expressing a LuxAB fusion were shown to function as a visible 
reporter in the eukaryote Nicotiana tabacum, underlining the use of bacterial luciferase as a 
cellular imaging technology in eukaryotic cells 113.  
The applications of bacterial luciferase are not limited to studying bacteria themselves; 
many studies have utilized bacterial luciferase in eukaryotic systems as well. A 1992 study used 
tetracycline-controlled transactivator-responsive luciferase constructs to monitor the highly 
sensitive luciferase expression as a measure of gene expression in HeLa cells 58. Expression of 
luciferase in this system was tightly controlled by the addition of tetracycline in a highly 
responsive manner that allowed the generation of an “on/off” control for mammalian genes. Due 
to the short half-life of luciferase the authors were able to observe a rapid shutdown of 
transcription upon the addition of tetracycline. The lux operon was first expressed natively in 
Saccharomyces cerevisiae in 2003, with slight modifications required to the system itself, paving 
the way for numerous other studies using bioluminescent eukaryotic cells 67. These studies 
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eventually lead to the generation of a human cell line autonomously expressing the bacterial lux 
operon 30. Using these cells, bioluminescent imaging can be performed using mammalian cell 
lines expressing the lux genes as probes. These cells have numerous advantages over traditional 
bioluminescent probes in that they do not require the addition of a substrate, have a low 
background level when used in a bioluminescent imager and have a long-lasting signal that can 
be easily detected over long time-courses. Bacterial luciferase systems do, however, require the 
use of greater numbers of reporter cells than firefly luciferase reporters in order to be  
detectable 29. In the future, eukaryotic-optimized lux systems will likely be further refined and 
optimized, reducing the potential downsides to their use and emphasizing the unique properties 
of the system. 
Another common use of bacterial luciferase as a reporter involves the imaging of live 
animals using non-invasive bioluminescent imaging and luciferase reporter strains. The non-
invasive nature of these types of imaging experiments come with the advantage of being able to 
track the same population of animals throughout an entire experiment; imaging the animals in a 
bioluminescent imager does not require their euthanization. The prolonged nature of 
bioluminescence also allows the study of reporters over a long period of time. Because whole 
animals are imaged at the same time, these studies allow the entire animal to be observed; you 
are not limited to looking at only the organs you already know are involved in a biological 
process 23. A 2011 study examining relapsing typhoid fever after antibiotic withdrawal used 
bioluminescent Salmonella to track their spread in mice 64. Using bioluminescent imaging they 
were able to determine that the mesenteric lymph nodes were a major reservoir for bacteria upon 
relapse. They observed that low levels of Salmonella remained in the MLNs even after antibiotic 
treatment and that the levels observed using imaging correlated well with bacterial counts when 
organs were homogenized and plated. Another study in 2009 examining murine intestinal 
colonization with E. coli using plasmid-based bacterial luciferase reporters found that bacterial 
counts correlated very closely with bioluminescent signals observed using a bioluminescent 
imager (BLI) 50. The authors concluded that intestinal colonization could be inferred directly 
from the bioluminescence observed in an animal. These and other studies all demonstrate the 
powerful in vivo applications of bacterial luciferase in its many forms.
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2.0 HYPOTHESIS AND OBJECTIVES 
2.1 Hypothesis 
Due to the cyclical lifestyle of many Salmonella serovars they are believed to spend 
significant periods of time in the environment 155. The ability to replicate and persist outside of a 
host, such as in an environmental reservoir, has been hypothesized to greatly enhance the 
transmission potential of a pathogen 3. It follows that factors involved in environmental 
persistence may also play a significant role in the transmission of Salmonella between hosts. 
Cellular aggregation and the formation of biofilms through the production of an extracellular 
matrix has been demonstrated to aid in the survival of Salmonella species in non-host 
environments and under varied stress-related conditions in vitro, such as prolonged  
desiccation 152, treatment with disinfectants 152,157, and exposure to antibiotics 112. These processes 
do not have a clear role in virulence 132,133, suggesting they may be involved in another, distinct 
part of the Salmonella lifestyle 151. 
 I hypothesize that the genetic factors involved in cellular aggregation and biofilm 
formation are vital to host-to-host transmission as well. A link between biofilm formation, 
environmental persistence and transmissibility has not yet been demonstrated, which is likely 
due to the lack of an appropriate model to study transmission. It is possible to generate mutant 
strains of Salmonella Typhimurium, a nontyphoidal serovar of Salmonella, which lack the 
transcriptional regulation necessary for producing biofilm by knocking out the gene csgD. CsgD 
is a transcriptional regulator that controls the expression of many biofilm-related extracellular 
compounds 54; ∆csgD mutants do not aggregate and form biofilm under conditions that induce 
biofilm formation in wild-type Salmonella 162. I hypothesize that Salmonella Typhimurium 
∆csgD mutants will have reduced transmission rates when compared to the wild-type in a murine 
model due to their inability to aggregate and form biofilms. 
 To test the transmission potential of many Salmonella Typhimurium strains I developed a 
murine model of Salmonella transmission during the course of my project. The purpose of this 
model is to monitor the spread of Salmonella Typhimurium from infected seeder mice to naive, 
uninfected mice in an experimental mouse population. By comparing the rates of transmission of 
both wild-type and mutant strains, I will gain insight into how these specific mutations alter the 
transmission potential of bacteria in our model and elucidate the role of these genes in the 
transmission process. Luciferase-producing Salmonella Typhimurium reporter strains I have 
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generated and bioluminescent imaging will be used to monitor the spread of Salmonella 
Typhimurium throughout a mouse population. Based on the findings of previous studies I 
hypothesize that the main route of infection in our model will be through the fecal-oral route, 
where uninfected mice become infected through exposure to fecal pellets contaminated with 
Salmonella 91. The goal is to be able to observe the onset and spread of infection before the 
presence of clinical signs in the mice, giving me a more precise and accurate quantification of 
the transmission dynamics in the model. 
2.2 Objectives 
The specific objectives of my Master’s project were as follows: 
 
1) Develop a working model of murine Salmonella Typhimurium transmission that allows for 
the study of genetic factors involved in the transmission process. 
2) Using this model, test specific genetic factors predicted to be involved in the transmission 
of Salmonella Typhimurium. 
3) Observe the temporal and spatial dynamics of murine Salmonella Typhimurium infection 
using a bioluminescent imager and Salmonella Typhimurium luciferase reporter strains. 
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3.0 MATERIALS AND METHODS 
3.1 Bacterial strains and culture conditions 
The Salmonella enterica subspecies enterica serovar Typhimurium (Salmonella 
Typhimurium) strains (both the wild-type and ∆csgD mutant) used in all experiments were 
derived from the ATCC 14028 type strain. Various Salmonella Typhimurium WT/∆csgD 
KanR/CamR luciferase reporter strains containing a chromosomal insertion of the Photorhabdus 
luminescens luxCDABE operon were used in all animal trials, imaging experiments and 
luciferase assays, and their generation is described below (referred to as Salmonella 
Typhimurium reporters). E. coli DH10B was used for general cloning and E. coli CC118 was 
used for replication of the pUC18R6KT-miniTn7T vector and its derivatives. 
To generate the bacterial challenges used for murine infections, strains were streaked 
onto LB agar (supplemented with 50 µg/mL kanamycin [Kan] or 10 µg/mL chloramphenicol 
[Cam]) from frozen stocks. Isolated colonies were selected and grown for 16 hours in LB broth 
at 37° C, shaking at 200 rpm. These cultures were then used to generate the bacterial challenges, 
described below. For luciferase assays, the strains assayed were grown for 16 hours in 5 mL LB 
broth cultures supplemented with the appropriate concentration of antibiotic depending on the 
assay (50 or 100 µg/mL Kan, 5, 7, or 10 µg/mL Cam, 5, 7, 9, 100 µg/mL ampicillin [Amp], or 
10 µg/mL tetracycline [Tet]). These cultures were diluted 1:600 into 150 µL assay media (i.e. LB 
broth, 1% Tryptone or LB broth without NaCl, supplemented with antibiotics), in a 96-well 
clear-bottomed black plate (Product #3631, Corning Life Sciences, Tewksbury, MA, U.S.A.) and 
overlaid with 50 µL of mineral oil. Luminescence and optical density (600 nm) measurements 
were performed every 30 minutes using a Victor X3 multi-label plate reader (Perkin-Elmer Life 
Sciences, Waltham, MA, U.S.A.). 
3.2 Modifications to the pUC18R6KT-miniTn7T delivery vector 
To facilitate cloning into the pUC18R6KT-miniTn7T plasmid 26 a poly-linker containing 
a PacI restriction site was inserted between the SacI and KpnI restriction sites contained in the 
multiple cloning site (MCS). The oligonucleotides Sac_Pac_Kpn1 and Sac_Pac_Kpn2 (see 
Appendix A) were annealed to generate the PacI poly-linker. pUC18R6KT-miniTn7T was 
digested with SacI and KpnI and the poly-linker was ligated into the MCS. The pHSG415-
tnsABCD and pUC18R6KT-miniTn7T-PacI vectors were used for all subsequent experiments. 
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3.3 Generation of the pCS26 sig70-16 CamR and TetR vectors 
To generate a chloramphenicol-resistant pCS26 sig70-16 vector 13 a promoterless version 
of this plasmid containing a CamR gene was used (pCS26cam), prepared by B.D. Jones, M.G. 
Surette and R. DeVinney. The sig70-16 promoter region of pCS26 was polymerase chain 
reaction (PCR) amplified using the pZE05 and pZE06 primers (see Appendix A), purified, and 
digested with BamHI and XhoI. This was then ligated into BamHI and XhoI-digested pCS26cam 
and electroporated into E. coli DH10B cells, which were incubated at 37° C for 1 hour in SOC 
media and plated on LB agar supplemented with 10 µg/mL Cam. Successful clones were 
screened by PCR using the same pZE05 and pZE06 primers as above. 
To generate a tetracycline-resistant pCS26 sig70-16 vector, the pACYC184 plasmid was 
PCR amplified using the primers TetExtractFor2 (containing an EcoRI site) and TetExtractRev2 
(containing a PstI site) (see Appendix A) to amplify the TetR gene and then digested with PstI 
and EcoRI. pCS26 sig70-16 CamR was then digested with PstI and EcoRI, ligated with the TetR 
gene and electroporated into E. coli DH10B cells. Potential transformants were incubated at 37° 
C for 1 hour in SOC and plated on LB agar supplemented with 7 µg/mL Tet. Potential clones 
were grown overnight in LB agar supplemented with 7 µg/mL Tet, and the resulting plasmids 
were purified and screened by PstI and EcoRI digestion.  
3.4 Cloning the luciferase construct into the Salmonella Typhimurium chromosome 
The pCS26 13 vectors (pCS26 sig70-16 KanR/CamR) were PCR amplified using the 
primers pCS26_Pac_FOR and pCS26_Pac_REV (see Appendix A) to amplify the region 
containing the bacterial luciferase operon (luxCDABE), the promoter (sig70-16), and the 
antibiotic resistance marker (KanR or CamR). The amplified PCR products (luxCDABE sig70-16 
KanR/CamR) were digested with PacI and ligated into the PacI-digested pUC18R6KT-
miniTn7T-PacI delivery vector to generate a Tn7 delivery vector containing the lux construct 
(luxCDABE sig70-16 KanR/CamR). The ligation mixture was electroporated into E. coli CC118 
cells followed by incubation in 1 mL SOC at 37° C for 1 hour to allow the pUC18R6KT-
miniTn7T-PacI- luxCDABE sig70-16 KanR/CamR construct to replicate. Successful clones were 
grown overnight in LB broth supplemented with 50 µg/mL Kan or 10 µg/mL Cam, as well as 
100 µg/mL Amp, and plasmid purification was performed. To screen the insert orientation of the 
luxCDABE insert into the Tn7 delivery vector, plasmids were digested with NotI, XbaI and 
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EcoRV and ran on a 1% agarose gel for 1 hour at 100 V. Differences in band sizes indicated 
whether the lux construct was ligated into the delivery vector in the “forward” or “reverse” 
orientation. 
The final delivery vectors were then electroporated into electrocompetent Salmonella 
Typhimurium ∆csgD cells containing the helper plasmid pHSG415-tnsABCD. Cells were 
incubated at 28° C in 1 mL SOC for 1 hour, and potential transformants were selected on LB 
agar supplemented with 50 µg/mL Kan or 10 µg/mL Cam and grown at 37° C overnight. 
Successful chromosomal insertion of the lux construct in any resulting transformants was 
confirmed using the primers glmSdetectFOR and glmSdetectREV (see Appendix A). These 
clones were used as donor strains to generate P22 phage lysates, as described below.  
3.5 P22 phage transduction 
Donor strains were streaked from frozen stocks onto LB agar supplemented with 
antibiotic (50 µg/mL Kan or 10 µg/mL Cam) and grown overnight at 37° C. Single colonies 
were selected from plates and grown in 5 mL LB broth for 8 – 16 hours, shaking at 200 rpm. P22 
phage lysates were prepared by mixing 1 mL overnight culture with 4 mL P22 phage broth, at an 
MOI of approximately 0.01 – 0.1 PFU/cell, and incubated at 37° C for 10 – 16 hours with 
agitation at 200 rpm. Cell debris was removed by centrifugation (13,500×g, 2 minutes), the 
supernatant was transferred to a glass screw-top vial and 500 µL of chloroform (100 µL per mL 
of supernatant) was added as a preservative. P22 phage lysates were stored at 4° C. 
Recipient strains were grown in 5 mL LB broth for 18 h at 37° C, shaking at 200 rpm. 
1:1,000 and 1:10,000 dilutions of the donor P22 phage lysate were prepared in 0.85% NaCl and 
were mixed with any recipient strain cultures at ratios of 0.2:1, 1:1, and 5:1. The P22 phage and 
strain mixture was incubated at 37° C for one hour, without shaking, to allow for phage 
adsorption and transduction. Cells were pelleted by centrifugation (13,500×g, 1 minute), 
resuspended in 1 mL LB broth, plated on LB agar supplemented with 10 mM EGTA and 50 
µg/mL Kan or 10 µg/mL Cam and incubated overnight at 37° C. To ensure that potential 
transductants did not contain lysogenic phage, colonies were selected and streaked out on EBU 
agar. White colonies were selected and the chromosomal region of insertion was PCR amplified 
using the primers pZE05/06 and glmSdetectFOR/REV (see Appendix A) and sequenced. 
Reporters whose sequences were confirmed were used for all subsequent experiments. 
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3.6 Luciferase assays 
Strains grown overnight at 37° C in 5 mL LB supplemented with antibiotic (50 µg/mL 
Kan, 10 µg/mL Cam, 100 µg/mL Amp or 10 µg/mL Tet) were diluted to a final dilution of 1:600 
in 96-well clear-bottomed black plates (Product #3631, Corning Life Sciences, Tewksbury, MA, 
U.S.A.) in the media being tested (LB broth, 1% Tryptone or LB broth without NaCl) 
supplemented with antibiotics (50 or 100 µg/mL Kan, 5, 7, or 10 µg/mL Cam, 5, 7, 9, 100 
µg/mL Amp, or 10 µg/mL Tet). Before starting the assay 50 µL of mineral oil was overlaid on 
the wells to prevent drying out of the cultures. All luciferase assays were performed using a 
Victor multi-label plate reader (either a Victor3V 1420 or Victor X3; Perkin-Elmer Life Sciences, 
Waltham, MA, U.S.A.). Absorbance (OD at 590 nm) and luciferase (counts per second [CPS]) 
measurements were taken every 30 minutes, with periodic agitation (1 minute, approximately 10 
minutes apart) for a total of 24 or 48 hours, as indicated. 
3.7 Drop dilutions for cell enumeration 
Dilution plates were prepared by adding 90 µL of PBS to each well in a 96-well clear 
plastic plate. A volume of 10 µL of the sample being enumerated was added to row A for a 
dilution of 1:10; 10 µL of sample from each row was then serially diluted through rows B – H, 
resulting in a series of dilutions from 10-1 to 10-8. A specified volume from each well (4 µL for 
bacterial cultures, 10 µL for organ/fecal samples) was plated on LB agar supplemented with 
antibiotics, with each dilution well growing as a small cluster of colonies forming units (CFU). 
Colony numbers at each dilution spot were enumerated by sight, with the ideal count ranging 
from 3 – 30 colonies. Final sample concentration was determined by the following formula:  
CFU/mL = colony count [CFU]*(1/drop volume [mL])*(1/dilution factor) 
3.8 Plating efficiency testing 
Strains being tested (WT Salmonella Typhimurium KanR and CamR sig70-16 reporters) 
were grown overnight in 5 mL LB broth cultures supplemented with either 50 µg/mL Kan or 10 
µg/mL Cam. Flasks of LB broth (50 mL) were inoculated with 500 µL of either strain and grown 
at 37° C. From these flasks, 0.7 OD stocks were created (0.7 OD equals approximately 7x108 
CFU) of each strain individually, as well as a combined stock containing equal numbers of both 
strains (7x108 CFU total). Each stock was serially diluted to 10-7 and plated in duplicate on LB 
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agar containing 50 or 100 µg/mL Kan, or 7, 10, or 15 µg/mL Cam to determine the plating 
efficiency of each strain on each media. 
3.9 Streptomycin MIC testing 
The WT Salmonella Typhimurium KanR reporter was grown at 37° C overnight in LB 
broth, with agitation at 200 rpm. LB broth supplemented with streptomycin was serially diluted, 
with 8 replicates, in a 96-well clear-bottomed black plate (Product #3631, Corning Life 
Sciences), resulting in the following concentrations of streptomycin: 512, 256, 128, 64, 32, 16, 8, 
4, 2, 1 and 0.5 mg/mL; a control column containing no streptomycin was included as well. A 5 
mL, 1x107 CFU/mL stock of Salmonella Typhimurium was prepared in LB broth, and 100 µL of 
this stock was pipetted into each well of the 96-well plate (each well had a final cell count of 
approximately 1x106 CFU). The 96-well plate was then left overnight at 37° C. OD590 readings 
were taken from each well using the Victor X3 multi-label plate reader (Perkin-Elmer Life 
Sciences) to determine the MIC of streptomycin with this strain. 
3.10 Design and cloning of sig70c10 and sig70c35 promoters 
The oligonucleotides sig70-16-10c2F and sig70-16-10c2R, and sig70-16-35c2F and 
sig70-16-10c2R (see Appendix A) were annealed to generate the phosphorylated Psig70c10 and 
Psig70c35 promoters. These promoters were ligated into BamHI and XhoI-digested and antarctic 
phosphatase-treated pCS26 sig70-16 KanR/CamR vectors, electroporated into E. coli DH10B 
cells, incubated in 1 mL SOC at 37° C and plated on LB agar supplemented with 50 µg/mL Kan 
or 10 µg/mL Cam. These vectors were then cloned into the Salmonella Typhimurium 
chromosome and donor P22 phage lysates were generated, as detailed above. 
3.11 Bioluminescent imaging 
All bioluminescent imaging was performed using an IVIS Lumina II bioluminescent 
imager (Caliper Life Sciences, Hopkinton, MA, U.S.A.). Mice were anesthetized using 2.5% 
isofluorane, with a chamber flow rate of 1.5 L/min O2 and IVIS flow rate of 0.3 L/min O2. 
Photographs and luminescence measurements were taken with an f/stop of 1.2, with variable 
binning and time values to obtain representative images. All final measurements were converted 
to radiance values (photons/s/cm2/sr) from counts per second (CPS). 
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3.12 Animal challenges and infections 
Female C57BL/6 mice (6 – 8 weeks old) were purchased from Jackson Laboratory (Bar 
Harbor, ME, U.S.A.) and were assigned to cage groups either manually or randomized through 
the use of a randomization table generated using Microsoft Excel. Mice had their ears notched to 
allow individual mice to be differentiated during the course of an experiment. Bacterial 
challenges were prepared in 100 mM HEPES (pH 8) at 1×104 – 1×107 CFU per 100 µL, 
depending on the trial. Cultures grown in LB broth at 37° C for 16 hours, with agitation, were 
diluted to the appropriate concentration in 100 mM HEPES. Challenges were delivered to mice 
by oral gavage in 100 µL volumes performed by VIDO Animal Care technicians. Competitive 
infections were performed using the same procedure, ensuring that both strains were present in 
the challenge at an approximately 1:1 ratio (i.e. in a 1×107 CFU challenge, both strains would be 
present at ~5×106 CFU). The two strains were differentially marked using either a KanR or CamR 
resistance marker, allowing for selection of both strains separately after the experiment. Each 
challenge was serially diluted and drop dilutions were plated to quantify the number of bacteria 
of each strain present in each challenge. 
3.13 Organ collection and processing from infected mice 
Mice were monitored over the course of each experiment for weight loss and the 
appearance of clinical signs of infection. Mice that had lost >20% of their starting weights 
(weight score = 3), typically 4 – 7 days post-infection, were humanely euthanized, either with 
isofluorane or by cervical dislocation. The spleen, liver, cecum and mesenteric lymph nodes 
(MLNs) of each mouse were harvested by a VIDO Animal Care technician and collected in a 2 
mL Eppendorf Safe-Lock Tube (Product #022363352, Eppendorf, Hamburg, Germany) 
containing 1 mL of PBS and a 5 mm stainless steel bead (Product #69989, Qiagen, Venlo, 
Netherlands). Organs were homogenized using a high-speed mixer mill (MM400; Retsch, Haan, 
Germany) for 4 minutes at 30 Hz. Homogenized organs were serially diluted and drop dilutions 
were plated to quantify the number of bacteria of each strain present in each organ. 
3.14 Streptomycin pre-treatment and challenge of C57BL/6 mice  
Mice were grouped into cages and had their ears notched according to the experimental 
challenge protocol (see above). Streptomycin pre-treatment was adapted from a previously 
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established protocol 7. Four hours prior to treatment with streptomycin, food and water were 
removed from the cages. 20 mg of streptomycin in 100 µL (from a stock solution of 200 mg/mL 
streptomycin sulfate) was delivered to each mouse by oral gavage. Food and water was 
immediately returned to each cage after treatment. Streptomycin treatment was always 
performed 24 hours before bacterial challenge. Food and water were removed from the cages 4 
hours before challenge. Mice were then challenged with 1×104, 1×105, 1×106 or 1×107 CFU of 
Salmonella Typhimurium, the exact dosage and strain depending on the particular trial. Water 
was returned to the cages immediately, and food was returned 2 hours after challenge. 
3.15 Fecal sample collection and processing 
To collect individualized fecal pellets, mice were isolated and housed in plastic isolation 
containers each day until 3 – 4 fecal pellets were shed and collected (typically <30 minutes). 
Fecal pellets were then transferred to 1.5 mL Eppendorf tubes. Individual fecal pellets were 
collected using sterile forceps and either transferred to 2 mL Eppendorf Safe-Lock Tubes 
(Product #022363352, Eppendorf, Hamburg, Germany) containing 1 mL of PBSA and a 5 mm 
stainless steel bead (Product #69989, Qiagen, Venlo, Netherlands) for immediate processing or 
transferred into 48- or 96-well plates for long-term storage. Fecal pellets were homogenized 
using a high-speed mixer mill (MM400; Retsch, Haan, Germany) for 4 minutes at 30 Hz. The 
number of Salmonella Typhimurium present in each fecal sample was determined by serially 
diluting and plating each sample by drop dilution. 
3.16 Collection and long-term storage of fecal pellets 
Fecal pellets selected for long-term storage were collected using two different methods. 
Fresh fecal pellets were collected as above and stored in 48- or 96-well plates. Other fecal pellets 
were collected in a manner to maximize the number of pellets collected by collecting all fecal 
pellets in a cage. For this, mice were transferred to clean cages and the entire contents of the old 
cage (i.e. bedding, fecal pellets, etc.) were collected. 3 pellets were sampled immediately, 
following the above procedure, to determine the number of bacteria being shed. Remaining 
pellets were taken and stored in either 48- or 96-well plates (Product #3548 and #3596, Corning 
Life Sciences, Tewksbury, MA, U.S.A.). Plates were covered with lids and stored on a bench top 
at room temperature for a period of up to 6 weeks. Each week 6 – 10 pellets were randomly 
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selected and sampled as above to determine the number of Salmonella Typhimurium present in 
each fecal sample after long-term desiccation and storage at room temperature. 
3.17 Experimental design of initial transmission trial 
Mice were randomly sorted into cages and their ears were notched based on randomized 
assortment determined in Microsoft Excel. Eight seeder mice (two per cage) that had been pre-
treated with streptomycin (as above) were challenged with 1×105 CFU of the WT Salmonella 
Typhimurium sig70-16 CamR reporter. The three groups of naive mice (five per cage) had 
different initial treatments: group 1 – untreated; group 2 – pre-treated with streptomycin as 
described above (the day before co-housing); and group 3 – fasted for 20 hours (16 hours before 
co-housing and 4 hours after co-housing with seeder mice).  Two seeder mice were randomly 
selected and placed into cages containing the naive mice; the two remaining seeder mice were 
left to observe. 
For the duration of the experiment, shedding of the seeder mice was monitored by 
collecting and processing 3 fecal pellets from each mouse daily, and all mice were monitored for 
clinical signs of infection and weight loss, as described above. Mice were euthanized when they 
scored a weight score of 3 and their organs were collected and processed as described above to 
quantify the bacteria present in their organs. 
3.18 Experimental design of short- and long-term transmission trial 
A total of 30 naive mice (five per cage) and 12 seeder mice (three per cage) were 
randomly sorted into cages and their ears were notched based on randomized assortment 
determined in Microsoft Excel.  The seeder mice were challenged with 1×105 CFU of one of the 
following sig70-16 reporter strains of Salmonella Typhimurium (one strain randomly assigned 
per cage): WT Salmonella Typhimurium KanR, Salmonella Typhimurium ∆csgD KanR, WT 
Salmonella Typhimurium CamR or Salmonella Typhimurium ∆csgD CamR. The challenges were 
delivered double-blinded, with both researchers and Animal Care staff blinded to which group 
received which challenge. These seeder mice were randomly co-housed with a group of 
streptomycin pre-treated naive mice for the duration of the experiment (groups 1 – 4). The two 
cages of naive mice that were not co-housed with seeder mice (groups 5 and 6) had their cages 
seeded with 200 desiccated fecal pellets; 100 fecal pellets shed from mice challenged with the 
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WT Salmonella Typhimurium reporter and 100 fecal pellets shed from mice challenged with the 
Salmonella Typhimurium ∆csgD reporter. Reciprocal groups of fecal pellets containing KanR 
and CamR Salmonella were used. 
For the duration of the experiment, shedding of the seeder mice was monitored by 
collecting and processing 3 fecal pellets from each mouse daily, and all mice were monitored for 
clinical signs of infection and weight loss, as described above. Mice were euthanized when they 
scored a weight score of 3 and their organs were collected and processed as described above to 
quantify the bacteria present in their organs. 
3.19 Ethics statement 
All animal experiments in these studies were conducted in accordance with the 
Guidelines of the Canadian Council on Animal Care and the Regulations of the University of 
Saskatchewan Committee on Animal Care and Supply. All animal experiments were performed 
under Animal Use Protocol #20110057, which was approved by the University of 
Saskatchewan’s Animal Research Ethics Board.  
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4.0 RESULTS 
4.1 Construction and characterization of Salmonella Typhimurium reporter strains 
4.1.1 Generation of Salmonella Typhimurium reporters 
To facilitate both in vitro and in vivo studies using Salmonella Typhimurium reporter 
strains and bioluminescent imaging (BLI), we generated luciferase reporters using a modified 
Tn7 transposition system. The overall objective of such a system was to chromosomally insert a 
luciferase reporter construct (lux construct) into the Salmonella chromosome, resulting in various 
reporter strains for use in subsequent imaging studies. The lux constructs themselves were 
sourced from the plasmid pCS26 (Figure 1A). The complete luciferase construct contained the 
Photorhabdus luminescens luxCDABE luciferase operon as a reporter, with expression controlled 
by a synthetic σ70-dependent promoter – sig70-16 – as well as an antibiotic resistance marker 
(Figure 1B). The sig70-16 promoter sequence was based on the consensus from many different 
σ70-controlled promoters in E. coli (described in detail in Section 4.1.7). Expression from this 
promoter was constitutive, due to the ubiquity of the σ70 sigma factor, resulting in reporters that 
constitutively expressed luciferase. Isolating and extracting the lux construct was achieved 
through digestion of pCS26 with PacI, removing the replication origin region of the plasmid.  
pCS26 was designed in a way that allowed this system to be modular: the reporter genes 
and the desired promoter could be easily excised and exchanged with other modules in order to 
design an appropriate reporter construct for any experiment. The reporter construct could be 
changed by digesting pCS26 with NotI, removing the luxCDABE operon and ligating in a new 
reporter. The promoter region could be changed by digesting pCS26 with XhoI and BamHI and 
ligating in a new promoter. Finally, the antibiotic marker was changed from kanamycin-resistant 
(KanR) to chloramphenicol-resistant (CamR) through a series of cloning steps (see Section 3.3); 
the CamR marker could be removed from the pCS26cam plasmid using EcoRI and PstI 
restriction sites. Each of these features allowed for the customization of the reporter construct 
prior to Tn7 transposition, resulting in a variety of potential reporter strains. In the following 
studies we utilized luciferase reporters, carrying both KanR and CamR resistance markers. 
Transposition through a Tn7-based system required two main elements: a delivery vector 
as a vehicle for the reporter construct and a helper plasmid encoding the transposition genes  
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Figure 1: pCS26 and the luciferase reporter construct. A) The plasmid pCS26 was 
used to generate luciferase constructs. The promoter site (green) is flanked by XhoI and 
BamHI sites. Expression of the reporter genes (yellow; luxCDABE operon derived from 
Photorhabdus luminescens) is driven by the promoter at this site. Reporter genes are 
flanked by NotI sites. An antibiotic resistance marker (red) allows for antibiotic selection; 
both kanamycin-resistant and chloramphenicol-resistant versions of the plasmid were 
used. PacI sites flank the full luciferase construct. B) The luciferase construct consists of 
the reporter genes (lux operon), a promoter (sig70-16) and an antibiotic resistance marker. 
This construct is isolated through digestion with PacI or PCR amplification and inserted 
into the bacterial chromosome using Tn7 transposition. 
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necessary for transposition. The delivery vector selected was a modified version of 
pUC18R6KT-miniTn7T 26 – pUC18R6KT-miniTn7T-PacI (Figure 2A). We modified the 
pUC18R6KT-miniTn7T vector by introducing a PacI site into its multiple cloning site (MCS). 
This was achieved by introducing a poly-linker containing a PacI site between the SacI and KpnI 
sites contained in the original MCS. After digesting pUC18R6KT-miniTn7T with both SacI and 
KpnI, we ligated the poly-linker into the delivery vector for efficient cloning of our various 
reporter constructs; PacI was used to extract the reporter construct from pCS26. The MCS in 
pUC18R6KT-miniTn7T-PacI was located between its Tn7R and Tn7L sites, and ligation of the 
reporter construct between these sites resulted in its integration into the bacterial chromosome 
through Tn7 transposition. The helper plasmid – pHSG415-tnsABCD – was designed by PCR 
amplifying the tnsACBCD operon from the plasmid pTNS2 26 and ligating it into pHSG415 
under the control of a chloramphenicol promoter (Figure 2B); this was done to increase the 
longevity of the tnsABCD genes in the cell. Our initial transposition attempts using pTNS2 were 
unsuccessful (MacKenzie, Waldner and White; unpublished data); since pTNS2 was a suicide 
vector (i.e. it does not replicate in Salmonella), we reasoned that it might have been cured from 
the cells before adequate amounts of the TnsABCD proteins could be produced. pHSG415-
tnsABCD contains a temperature-sensitive origin of replication that allowed for curing of cells in 
a more controllable manner, and as a consequence, better tnsABCD expression.  
Ligation of the PacI-digested reporter construct into PacI-digested pUC18R6KT-
miniTn7T-PacI resulted in two possible insert orientations due to the use of single restriction 
enzyme in the cloning. Delivery vectors containing the reporter construct in the orientation 
shown in Figure 1B were referred to as the forward orientation, while delivery vectors containing 
the reporter construct in the opposite orientation were referred to as the reverse orientation. As 
Tn7 transposition is orientation-specific, subsequent chromosomal insertion would occur in the 
same orientation as in the delivery vector. To screen the orientation of the miniTn7T-reporter 
constructs, we digested these vectors with XbaI, EcoRV and NotI and ran them on a 1% agarose 
gel (Figure 3). Delivery vectors containing the reporter construct in the forward orientation 
resulted in visible bands at approximately 3850 bp, 3300 bp, 1900bp and 1300 bp after digestion 
while vectors containing the reporter construct in the reverse orientation resulted in visible bands 
at approximately 5100 bp, 3850 bp and 1650 bp. This difference was easily distinguishable, with  
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Figure 2: The delivery vector, pUC18R6KT-mini-Tn7-PacI, and helper plasmid, pHSG415-
tnsABCD. A) pUC18R6KT-mini-Tn7T-PacI is the delivery vector. DNA contained between the 
Tn7R and Tn7L sites (grey) is excised from the plasmid and inserted into the chromosome. A PacI 
site was engineered into the MCS to facilitate the insertion of reporter constructs. An ampicillin 
resistance gene (red) is present to allow for antibiotic selection. B) pHSG415-tnsABCD is the 
helper plasmid containing the tnsABCD operon (blue) encoding the transposition genes. An 
ampicillin resistance gene (red) is present to allow for antibiotic selection. It is temperature 
sensitive to allow for easy curing of the helper plasmid post-transposition. 
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Figure 3: Digests of pUC18R6KT-mini-Tn7T plasmids to screen for insert 
orientation. Plasmids were digested with EcoRV, NotI and XbaI and ran on a 1% 
agarose gel to screen the insert orientation of the lux construct. Gel was stained in 0.5 
µg/mL ethidium bromide for 10 minutes. Plasmids containing the insert in the forward 
orientation contain visible bands at approximately 3850 bp, 3300 bp, 1900 bp and 1300 
bp (seen in lanes 1, 2, 6, 8 and 10). Plasmids containing the insert in the reverse 
orientation contain visible bands at approximately 5100 bp, 3850 bp and 1650 bp (seen 
in lanes 3, 4, 5, 7 and 9). All band size estimates made using Geneious 6.1.7 84. 
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the vectors in lanes 1, 2, 6, 8 and 10 having forward orientation reporter constructs and the 
vectors in lanes 3, 4, 5, 6 and 9 having reverse orientation reporter constructs.  
Salmonella Typhimurium ∆csgD electrocompetent cells harboring the pHSG415-
tnsABCD plasmid were electroporated with the desired miniTn7T-lux reporter construct delivery 
vectors resulting in transposition of the reporter construct into the bacterial chromosome 
downstream of the glmS gene. Transposition in Salmonella Typhimurium using this system 
typically resulted in successful transposition with a success rate of approximately 80% (Table 1); 
depending on the experiment, it was successful in 55 – 100% of clones tested. Transformants 
were then screened by antibiotic resistance and light production, and P22 phage were used to 
move the reporter construct into a clean genetic background. The final reporter strains were 
sequenced for confirmation of successful transposition, amplifying both the promoter region 
(using the pZE05/06 primers; see Appendix A) as well as the regions between the construct itself 
and the bacterial chromosome (using the glmSdetectFOR/REV primers; see Appendix A). 
Salmonella Typhimurium luciferase reporter strains were generated with constructs in both the 
forward and reverse orientations, in both wild-type and ∆csgD genetic backgrounds and with 
both kanamycin and chloramphenicol resistance markers (these reporter strains are referred to as 
Salmonella Typhimurium luciferase reporters, with either KanR or CamR resistance). 
4.1.2 Orientation of lux insert does not affect luciferase expression 
To determine whether the construct orientation affected expression of the luxCDABE 
operon from the Salmonella chromosome we continuously monitored light production from each 
strain over a period of 24 hours. Large differences in the expression from these strains would 
have been undesirable as our goal was to have a library of reporters whose luciferase expression 
could be used to compare the reporters with each other in vivo. Salmonella Typhimurium ∆csgD 
reporter strains containing the reporter construct in either orientation were grown in 96-well 
plates in LB broth at a temperature of 30° C (Figure 4A). Reporters containing reverse 
orientation constructs (grey) had higher levels of luciferase expression over the course of the 
experiment when compared to reporters with forward orientation constructs (red). The luciferase 
expression of forward orientation clones clustered tightly with peak luciferase expression of 
approximately 5×104 counts per second (CPS) while the luciferase expression of reverse 
orientation clones was more variable with a range of peak expression from 5×104 to 7×104 CPS.  
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Experiment # clones tested # clones positive Success rate (%) 
KanR sig70-16 
reporters 16 16 100 
CamR sig70-16 
reporters 16 13 81 
sig70c10/c35 
reporters 11 6 55 
Table 1: Success rate of Tn7 transposition. The success rate of clones tested after chromosomal 
insertion of the lux reporter construct using our Tn7 transposition system. The percentage of clones 
that tested positive for insertion of the reporter construct was recorded after three separate 
experiments. Success rate calculated as (# clones positive)/(# clones tested). 
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Figure 4: The insert orientation of the luxCDABE construct affects temporal luciferase expression. 
A) Luciferase expression of Salmonella Typhimurium ∆csgD reporter strains grown in LB broth at 30° 
C. Reporters containing the lux construct in both the forward (red) and reverse (grey) orientation were 
assayed during the same experiment. Luciferase expression (measured as counts per second [CPS]) was 
assayed over a 24-hour period. Each line represents the mean luciferase expression of three replicates 
from one individual clone. 4 forward orientation clones and 18 reverse orientation clones were assayed. 
B) Growth of the reporter strains was monitored simultaneously by measuring the absorbance (OD590) 
values of the cultures. Reporters containing the lux construct in both the forward (red) and reverse (grey) 
orientation were assayed during the same experiment. Each line represents the mean OD of three 
replicates of one individual clone. 
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The growth of the two strains was also monitored throughout the course of the experiment, 
measured as the absorbance (OD590 values) of each well during growth (Figure 4B). Both strains 
had similar growth patterns and peak absorbance values throughout the experiment, as well as 
similar expression dynamics. The differences in luciferase expression between the reporters 
containing constructs in either orientation did not appear to be explained by differences in 
growth. It appeared that reporters containing the luciferase construct in the reverse orientation 
had higher expression during the course of the experiment. Because of this, we decided to use 
reporters containing reverse orientation constructs for all subsequent experiments. 
4.1.3 The antibiotic marker affects luciferase expression 
As described above, isogenic reporter strains were generated containing either a 
kanamycin resistance marker (KanR) or chloramphenicol resistance marker (CamR). The 
different markers were used in order to facilitate studies where two strains could be used and 
then differentiated later on using antibiotic selection. To determine whether the antibiotic 
resistance marker affected the luciferase expression of these strains we performed a luciferase 
assay monitoring light production over a period of 48 hours. Salmonella Typhimurium ∆csgD 
reporter strains containing either resistance marker were grown in 96-well plates in LB broth 
supplemented with either 50 µg/mL kanamycin or 10 µg/mL chloramphenicol at a temperature 
of 30° C. The luciferase data collected indicated that the KanR reporters (green) had significantly 
higher levels of expression compared to the CamR reporters (blue), peaking at approximately 
5.5×104 CPS versus approximately 4.5×104 CPS, respectively (Figure 5A). The growth of the 
two strains showed that the KanR strain grew at elevated levels as well, reaching peak OD590 
values higher than the CamR strain after 48 hours of growth (Figure 5B). These results suggest 
that the luciferase expression of the two strains was different, although the KanR reporter was 
also able to grow more efficiently in the test media than the CamR strain. Whether the differences 
in luciferase expression could be entirely attributed to differences in growth was unclear, but the 
expression dynamics of the two reporter strains did appear to be very similar.   
4.1.4 The antibiotic marker does not affect plating efficiency 
To test the plating efficiency of both the KanR and CamR reporter strains we examined 
their recovery after preparing and plating a test inoculum on various growth media. This was  
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Figure 5: The antibiotic marker affects luciferase expression. A) Luciferase expression of Salmonella 
Typhimurium ∆csgD reporter strains grown in LB broth at 30° C supplemented with the either 50 µg/mL 
kanamycin or 10 µg/mL chloramphenicol. Reporters containing either a kanamycin resistance marker (green) or 
a chloramphenicol resistance marker (blue) were assayed during the same experiment. Luciferase expression 
(measured as counts per second [CPS]) was assayed over a 48-hour period. Each line represents the mean 
luciferase expression of three replicates from one individual clone. 4 KanR clones and 6 CamR orientation clones 
were assayed. Significance was determined using multiple t tests. B) Growth of the reporter strains was 
monitored simultaneously by measuring the absorbance (OD590) values of the cultures. Reporters containing 
either a kanamycin (green) or chloramphenicol (blue) resistance marker were assayed during the same 
experiment.  
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done to test various concentrations of antibiotics and ensure that the concentrations used to plate 
samples during an experiment would not alter the recovery levels of our reporter strains. Two 50 
mL cultures of LB were inoculated with 500 µL of either the KanR or CamR reporter and 
incubated at 37° C for approximately 3 hours. From these flasks, 1 mL 0.7 OD600 stocks 
(equaling approximately 7×108 CFU) were made of each strain, and these stocks were used to 
generate three different inocula: one containing the KanR reporter, one containing the CamR 
reporter and one containing both strains at an equal ratio (to test the recovery of both strains in a 
competitive infection). Each inocula was plated in triplicate on a series of LB plates 
supplemented with 7, 10 or 15 µg/mL chloramphenicol, 50 or 100 µg/mL kanamycin or no 
antibiotic and grown at 28°C for approximately 16 hours. Colony counts were performed, and 
the average CFU counts of each inocula on each media were calculated (Table 2). 
The CamR reporter was recovered from LB + Cam plates at similar levels across the 
various antibiotic concentrations. Its control growth on LB plates was 4.42×107 CFU/mL, with 
similar levels on Cam7 (4.17×108 CFU/mL), Cam10 (4.75×107 CFU/mL) and Cam15 (4.79×107 
CFU/mL) as well as no growth on any LB + Kan plates, suggesting the antibiotic concentration 
had no effect on the recovery of this strain. The KanR reporter had similar results with control 
growth of 3.75×108 CFU/mL, similar recovery on Kan50 (3.88×108 CFU/mL) and Kan100 
(3.21×108 CFU/mL) plates as well as no growth on any LB + Cam plates. Each strain in the 
inoculum containing both strains was expected to be recovered at approximately half the levels 
of each single-strain inocula. This was the case on all plates tested, with mean levels on Cam7 
(2.42×108 CFU/mL), Cam10 (2.42×108 CFU/mL), Cam15 (2.33×108 CFU/mL), Kan50 (1.71×108 
CFU/mL) and Kan100 (1.71×108 CFU/mL). This suggested that even when grown in the same 
inoculum both strains could be recovered at expected levels on all media tested. For our 
subsequent experiments we used LB + Cam10 and LB + Kan50 plates for the recovery of 
Salmonella from both in vitro and in vivo experiments. 
4.1.5 Salmonella Typhimurium reporter strains are susceptible to streptomycin 
Many of our animal experiments used streptomycin as a method to disrupt the resident 
microbiota of a mouse prior to challenge with Salmonella. We wanted to test whether our 
reporter strains were susceptible to streptomycin in vitro or if we could continuously supplement 
our mice with streptomycin. We set up a 96-well plate containing LB media supplemented with  
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Strain Cam7 Cam10 Cam15 
WT CamR 4.17×108 4.75×108 4.79×108 
WT KanR 0 0 0 
WT CamR/WT KanR 2.42×108 2.42×108 2.33×108 
    
Strain Kan50 Kan100 LB 
WT CamR 0 0 4.42×108 
WT KanR 3.88×108 3.21×108 3.75×108 
WT CamR/WT KanR 1.71×108 1.71×108 3.83×108 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Plating efficiency of Salmonella Typhimurium reporters on various media. Inocula 
containing Salmonella Typhimurium reporter strains were plated on various media and the recovery of 
each strain was calculated. Inocula contained either a single strain (CamR or KanR) or both strains in the 
same inoculum (CamR/KanR). Each value represents the mean value of an inoculum plated in triplicate. 
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streptomycin at concentrations from 512 – 0.5 mg/L and inoculated these with the Salmonella 
Typhimurium KanR reporter. The plate was incubated at 37° C for 16 hours and afterwards the  
wells were checked for growth through their OD590 values. The minimum inhibitory 
concentration of streptomycin (MIC) for our Salmonella Typhimurium reporter strain was 256 
mg/L (Table 3); at 128 mg/L two wells were positive for growth of Salmonella and from 64 – 0.5 
mg/L all of the wells tested were positive for growth. Since streptomycin at these levels would 
be sufficient to prevent the growth of our reporter strains, we determined that any streptomycin 
treatments would need to be single treatments at the start of an experiment rather than sustained 
treatment over its entire time course. 
4.1.6 Salmonella Typhimurium reporter strains are detectable in feces, organs and live 
mice 
The Salmonella reporter strains were designed for use in in vivo bioluminescent studies 
using a bioluminescent imager (BLI). To test the utility of these strains and ensure that they 
could be detected in a variety of in vivo applications we monitored them in different situations 
using a BLI. Mice were challenged with Salmonella Typhimurium reporters and imaged in 
different situations; representative images from different experiments were taken (Figure 6). 
Mice that had been pre-treated with streptomycin prior to challenge had detectable Salmonella in 
their digestive tracts at one day post-challenge (Figure 6A). Regions of high luciferase counts 
appeared as red and yellow, while regions of lower luciferase counts appeared as blue and green. 
This suggested that Salmonella was present in these mice at high levels. Fecal pellets that had 
been shed from mice challenged with Salmonella Typhimurium contained detectable Salmonella, 
suggesting that the luciferase expression of our reporters persisted throughout the mice and 
continued after being shed (Figure 6B); Salmonella was detectable in each individual pellet. 
Once the mice began to show signs of systemic Salmonella infection and were euthanized, their 
organs (spleen, liver, digestive tract [including cecum] and mesenteric lymph nodes [MLNs]) 
were arranged and imaged (shown in Figure 6C). The spleen, livers, digestive tract and MLNs 
were all colonized with Salmonella and could be detected reliably at high levels. Finally, organ 
samples that had been processed by homogenization and plated on KanR or CamR media to select 
for Salmonella were imaged for detection (Figure 6D). Drop dilutions were performed and 
individual colonies could be detected using the BLI, demonstrating the power of this technology 
and the utility of our reporter strains in vivo. 
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Streptomycin 
concentration (mg/L) 0 512 256 128 64 32 16 8 4 2 1 0.5 
Wells with positive growth 8 0 0 2 8 8 8 8 8 8 8 8 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Streptomycin MIC for a Salmonella Typhimurium KanR reporter strain. A 96 well plate 
containing LB media supplemented with varying concentrations of streptomycin was inoculated with a 
Salmonella Typhimurium KanR reporter strain. The plate was incubated at 37° C for 16 hours, and the 
absorbance (OD590) of each well was assayed as measure of growth.  
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Figure 6: Luciferase reporter strains are detectable using a bioluminescent imager (BLI). Female 
C57BL/6 mice were challenged with Salmonella Typhimurium luciferase reporter strains and were 
detected in: A) live mice anesthetized and imaged in the BLI; B) fecal pellets shed from these mice 
and imaged in the BLI; C) the spleen, liver, digestive tract (including cecum) and mesenteric lymph 
nodes (MLNs) of these mice once euthanized and imaged in the BLI; and D) homogenized organ 
samples from these mice that were plated on selective media, grown overnight and imaged in the BLI. 
Color scale illustrates the levels of luciferase detected, as measured by luminescence.  
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4.1.7 Generation of new sig70-16-based promoters 
Many of the images generated using the BLI were taken using reporters containing the 
sig70-16 promoter (Figure 6). One problem we encountered using these strains was that they 
were difficult to detect in live mice and were typically only detectable immediately after 
challenge or just prior to the time of euthanization. To determine whether the magnitude of 
luciferase expression from this promoter was leading to this difficulty we designed new, 
modified promoters that resulted in elevated levels of luciferase expression. As explained in 
Section 4.1.1, the reporter system was designed to be a modular system allowing for the insertion 
of new promoters, resulting in a large number of possible reporter constructs (Figure 7). The 
base sig70-16 promoter sequence was designed based on the consensus sequences of many 
different σ70-dependent promoters in E. coli 86,153. The σ70 sigma factor (encoded by the gene 
rpoD) is the major sigma factor in Salmonella and E. coli and is expressed largely during 
exponential growth 76,130. The sig70-16 promoter was one of several σ70-dependent promoters 
that was selected from a library of synthetic promoters, containing slight degeneracies from the 
σ70 consensus sequence; its promoter sequence was 5’-CTCGAGAATAATTCTTTACATTTA- 
TGCTTCCGGCTCGTATTCTACGTGCAATTGGATCC-3’ (possible degenerate positions 
underlined) 86. We reasoned that restoring the sig70-16 promoter sequence back to either the 
consensus -10 or -35 sequences might increase the promoter strength. These regions, as well as 
the spacer sequence between them, are recognized by the σ70 sigma factor and play a role in the 
initiation of transcription 130; more efficient recognition should result in greater expression from 
the new promoter. We did not return both regions to the consensus sequence to try and avoid 
expression levels that would have negative impacts on other cellular processes. The two new 
promoters were termed sig70c10, in which we returned the -10 region to the consensus sequence 
and left the -35 sequence degenerate, and sig70c35, in which we returned the -35 region to the 
consensus sequence and left the -10 sequence degenerate (Figure 8A). Both were achieved by 
altering one or two nucleotides from the original sig70-16 promoter sequence. 
The luciferase expression from pCS26 harboring the sig70c10 or sig70c35 promoters was 
monitored in E. coli DH10B cells during a 48-hour growth period (Figures 8B and 8C). pCS26 
containing the original sig70-16 promoter (red) had expression levels that peaked around 1×104 
CPS, while sig70c10 (blue) and sig70c35 (green) promoters resulted in luciferase expression 
levels that peaked around 3×104 CPS and 7×104 CPS, respectively (Figure 8B). The new  
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Figure 7: Tn7 transposition system allows for a suite of reporter constructs. A) The general 
reporter construct has three main features: an antibiotic resistance marker, a promoter that controls the 
expression of the reporter construct and the reporter genes themselves. B) Constructs can be 
customized to the needs of an experiment. Both kanamycin-resistant (green) and chloramphenicol-
resistant (blue) reporters are available. Luciferase reporters (yellow) are available currently, with the 
ability to add other reporters in the future. Three varying levels of reporter gene expression are 
available with 1× (red), 3× (blue) and 10× (green) expression levels, as well as the ability to insert any 
other promoter of interest. 
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Figure 8: Small nucleotide alterations in the -10 and -35 promoter regions result in higher luciferase 
expression in pCS26. A) The plasmid pCS26 contains the luxCDABE operon under the control of a 
synthetic, σ70-driven promoter (sig70-16). Slight alterations in the -10 or -35 sequences in the promoter 
(bolded nucleotides) were introduced, bringing these regions back to the consensus sequence. The sig70c10 
promoter contains the -10 consensus sequence, while the sig70c35 promoter contains the -35 consensus 
sequence.  B) Peak luciferase expression from pCS26 plasmids containing the sig70-16 (red), sig70c10 
(blue) or sig70c35 (green) promoters in E. coli DH10B cells grown in LB broth at 37° C. Peak luciferase 
expression (measured as counts per second [CPS]) was determined to occur approximately 10 hours into a 
48 hour assay (see 8C). Each bar is the result of the mean of multiple biological replicates. C) Luciferase 
expression of E. coli DH10B cells harboring the pCS26 plasmid with the sig70-16 (red), sig70c10 (blue) or 
sig70c35 (green) promoter. Reporters were grown in LB broth at 37° C. Luciferase expression (measured as 
counts per second [CPS]) was assayed over a 48-hour period. D) Peak luciferase expression from 8A, 
separated by antibiotic resistance marker. Expression was measure from both KanR (solid bars) and CamR 
(hatched bars) reporters.  
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promoters resulted in expression levels that were approximately 4 (sig70c10) or 10 (sig70c35) 
times higher than the sig70-16 promoter (Figure 8B and 8C), meaning that small nucleotide 
alterations (either one or two nucleotides) in the -10 and -35 regions of the promoter were 
sufficient to significantly increase the expression of downstream genes while retaining the 
original expression dynamics. We did notice that E. coli cells harboring pCS26 CamR reporter 
plasmids tended to have higher expression than cells harboring pCS26 KanR reporter plasmids 
containing either the sig70c10 and sig70c35 promoter (Figure 8D); there was a significant 
difference in the expression levels between the KanR and CamR vectors with these promoters.  
To test the luciferase expression of reporter plasmids containing these new promoters in 
Salmonella we electroporated the pCS26 vectors containing the modified promoters into 
Salmonella Typhimurium ∆csgD cells and performed the same luciferase assay to monitor their 
expression over 48-hours (Figure 9A). Both KanR and CamR versions of the pCS26 vector were 
tested. The same general trend was seen in Salmonella Typhimurium, with the new promoters 
having elevated expression levels, but unlike E. coli, the expression levels of the three promoters 
did not separate into discrete groups. Instead, the three groups appeared as more of a gradual 
progression from low expression to high expression. We separated the pCS26 KanR and CamR 
data into separate groups and observed that the pCS26 KanR peak expression profiles were 
similar to E. coli, with peak sig70-16 expression of approximately 0.5×104 CPS, peak expression 
from sig70c10 (blue) at ~2×104 CPS (approximately 3x higher) and expression from sig70c35 
(green) at ~3.0×104 CPS (approximately 5x higher) (Figure 9B). In contrast, the pCS26 CamR 
expression profiles peaked around 1 – 1.5×104 CPS with either of the new promoters (Figure 
9B); these values did not change even when expression was assayed in media supplemented with 
less chloramphenicol (i.e. 7, 9 and 10  µg/mL; data not shown). This data suggested that 
expression from the pCS26 CamR vector was impaired in Salmonella when compared to the 
KanR reporters. However, when the new luciferase reporter constructs containing the sig70c10 
and sig70c35 promoters were inserted into the Salmonella chromosome through transposition we 
did not observe the same defect in luciferase expression (Figures 9C and 9D), suggesting it could 
be an artifact of expression from the pCS26 CamR plasmid in Salmonella Typhimurium.  
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Figure 9: The same promoter alterations produce varying levels of luciferase expression in Salmonella 
Typhimurium. A) Luciferase expression of Salmonella Typhimurium ∆csgD cells harboring the pCS26 
plasmid with the sig70-16 (red), sig70c10 (blue) or sig70c35 (green) promoter controlling luciferase 
expression. Grown in LB broth at 37° C supplemented with either 50 µg/mL kanamycin or 10 µg/mL 
chloramphenicol. Luciferase expression (measured as counts per second [CPS]) was assayed over a 48-hour 
period. B) Peak luciferase expression from pCS26 plasmids containing the sig70-16 (red), sig70c10 (blue) or 
sig70c35 (green) promoters controlling luciferase expression in Salmonella Typhimurium ∆csgD cells 
grown in LB broth at 37° C, supplemented with antibiotic. Expression was measured from both pCS26 KanR 
(solid bars) and pCS26 CamR (hatched bars). Cells harboring pCS26 CamR were grown in media 
supplemented with 5, 7 and 10 µg/mL chloramphenicol, and this data is representative. Peak luciferase 
expression (measured as counts per second [CPS]) was determined to occur approximately 11 hours into a 
48-hour assay (see 9A). Each is the result of the mean of multiple biological replicates. C) Luciferase 
expression of Salmonella Typhimurium ∆csgD reporter strains after chromosomal insertion of the lux 
reporter construct. Reporters with the sig70-16 (red), sig70c10 (blue) or sig70c35 (green) promoters were 
measured, grown in LB broth at 37° C supplemented with either 50 µg/mL kanamycin or 10 µg/mL 
chloramphenicol. Luciferase expression (measured as counts per second [CPS]) was assayed over a 48-hour 
period. D) Peak luciferase expression from Salmonella Typhimurium reporters containing the sig70-16 (red), 
sig70c10 (blue) or sig70c35 (green) promoters controlling luciferase expression grown in LB broth at 37° C, 
supplemented with antibiotic. Expression was measured from both KanR (solid bars) and CamR (hatched 
bars) reporters. Peak luciferase expression (measured as counts per second [CPS]) was determined to occur 
approximately 8.5 hours into a 48-hour assay (see B). Each is the result of the mean of multiple biological 
replicates.  
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4.1.8 Comparing luciferase detection of reporter strains in C57BL/6 mice 
To determine whether the sig70c10 and sig70c35 promoters increased the visibility of our 
reporter strains in vivo we performed a series of animal experiments using a BLI for detection. 
Mice were pre-treated with streptomycin, challenged with Salmonella Typhimurium reporters 
containing the sig70-16, sig70c10 or sig70c35 promoter and imaged one day post-challenge. We 
were able to detect the reporters containing each promoter in most mice one day post-challenge 
(Figures 10A – C). Mice challenged with the sig70-16 reporter had peak luciferase expression 
levels of approximately 400 CPS (Figure 10A), while those challenged with the sig70c10 
reporter had peak levels of 1,200 CPS (Figure 10B) and sig70c35 reporters had peak levels of 
3,000 CPS (Figure 10C). Similar to our in vitro findings, the peak luciferase levels represented 
approximately 3 and 7.5 times higher levels than the sig70-16 promoter. Mice were euthanized 
after the onset of severe clinical signs and their organs (spleen, liver, digestive tract and MLNs) 
were examined in the BLI as well. Mice that were colonized with the sig70-16 reporter had peak 
luciferase expression levels of approximately 600 CPS (Figure 10D) while those colonized with 
sig70c10 had peak levels of 1,000 CPS (Figure 10E) and sig70c35 had peak levels of 50,000 
CPS (Figure 10F). This proved that the modified promoters allow for increased Salmonella 
detection in vivo, both in live mice as well as in their internal organs. The peak detection levels 
did not appear to follow the same trend in the organs, with the sig70c10 promoter resulting in <2 
times the expression as the sig70-16 promoter and the sig70c35 promoter resulting in >80 times 
the expression as the sig70-16 promoter; it is possible that this was correlated with the bacterial 
load in each organ.  
As mentioned previously many of our animal experiments involved pre-treating mice 
with streptomycin prior to challenge with Salmonella. We therefore also compared mice that had 
been pre-treated with streptomycin to those that had not, and observed whether there was a 
difference in detection. In the previous experiment we also used groups of mice that did not 
receive pre-treatment with streptomycin and were challenged with the sig70-16, sig70c10 or 
sig70c35 reporters. A representative image of the untreated group was taken (Figure 11A); we 
were unable to detect any luciferase from our reporters in untreated mice, even when using the 
sig70c35 reporters, which had the highest levels of luciferase expression. In contrast, we detected 
luciferase expression from our reporters in all streptomycin pre-treated mice on day 1 post-
challenge (Figure 11B; sig70-16 reporter shown); however detection of these strains tapered off  
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Figure 10: Salmonella Typhimurium reporter strains have varying levels of luciferase expression in 
vivo. Female C57BL/6 mice were pre-treated with streptomycin then challenged with the Salmonella 
Typhimurium reporters containing the following promoters: sig70-16 (A, D), sig70c10 (B, E) or sig70c35 
(C, F). Mice were anesthetized 1 day post-challenge and imaged on a bioluminescent imager. 4 – 5 days 
post-challenge, mice were euthanized and their organs (spleen, liver, cecum and MLNs) were recovered 
and imaged. Peak luciferase values (measured in CPS) are indicated. 
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Figure 11: Pre-treatment with streptomycin results in greater in vivo detection of 
Salmonella Typhimurium luciferase reporter strains. A) Female C57BL/6 mice were 
challenged with 1×107 CFU of a Salmonella Typhimurium luciferase reporter strain. Mice were 
then anesthetized and imaged using a bioluminescent imager 1 day post-challenge. B) Female 
C57BL/6 mice were challenged with 1×105 CFU of a Salmonella Typhimurium luciferase 
reporter strain after pre-treatment with 20 mg of oral streptomycin. Mice were then anesthetized 
and imaged using a bioluminescent imager 1 day post-challenge.  
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after day 1. Upon the onset of severe clinical signs, the reporters in some mice of both groups 
were detected, typically the day before euthanization, but not in all the mice that were tested. It 
appeared as though untreated mice had low detection of our modified reporters as well as the 
original sig70-16 reporters, suggesting that the difficulty in detection was due to some inherent 
property in the mice that streptomycin treatment overcame, regardless of the reporter used. 
4.1.9 Generation and testing of the tetracycline-resistant pCS26 sig70-16 vector 
To further strengthen our reporter library we generated a tetracycline-resistant (TetR) 
version of the pCS26 plasmid with the intent of generating TetR reporter strains. The TetR gene 
was PCR amplified from the pACYC184 plasmid and the resulting PCR product was digested  
using PstI and EcoRI. The digested TetR was then ligated into a PstI- and EcoRI-digested pCS26 
sig70-16 plasmid to generate a pCS26 sig70-16 TetR vector encoding a tetracycline resistance 
marker as well as the luxCDABE luciferase operon. To test luciferase expression from this 
plasmid in Salmonella we electroporated the pCS26 sig70-16 TetR vector into Salmonella 
Typhimurium ∆csgD cells and monitored the expression over a 48-hour growth period. 
Luciferase expression from the pCS26 TetR vector was highly elevated compared to the KanR 
and CamR vectors (Figure 12A). The variability in expression was also greater than the KanR and 
CamR vectors, resulting in a large spread in the data. When growth of the reporter strains was 
measured, clones containing the TetR vector appeared to have depressed growth levels compared 
to clones containing the KanR and CamR vectors (Figure 12B). This indicated that an elevated 
growth rate was not the cause of elevated luciferase expression. In an attempt to normalize the 
growth of the TetR clones, we repeated the experiment in LB media supplemented with 5, 7, 9 or 
10 µg/mL tetracycline; however this did not appreciably change the expression parameters of the 
TetR pCS26 sig70-16 vector (Shivak and White, unpublished data). The pCS26 TetR peak 
expression levels were approximately 8.5×104 CPS, which was approximately 6 times the peak 
expression from the KanR vector (green) and approximately 9 times the peak expression from the 
CamR vector (blue) (Figure 12C). Although the standard deviation in peak expression of the TetR 
clones was large, the expression was significantly higher than pCS26 vectors containing either 
KanR or CamR markers. For this reason we stopped the development of any TetR luciferase 
reporters.  
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Figure 12: pCS26 sig70-16 TetR has elevated luciferase expression and reduced growth. A) 
Luciferase expression of Salmonella Typhimurium ∆csgD cells harboring the pCS26 sig70-16 
plasmid with a KanR (green), CamR (blue) or TetR (black) antibiotic resistance marker. Grown in LB 
broth at 37° C supplemented with 50 µg/mL kanamycin, 10 µg/mL chloramphenicol or 7 µg/mL 
tetracycline. Luciferase expression (measured as counts per second [CPS]) was assayed over a 48-
hour period. B) Growth of the reporter strains was monitored simultaneously by measuring the 
absorbance (OD590) values of the cultures. Reporters containing KanR (green), CamR (blue) or TetR 
(black) antibiotic resistance marker were assayed during the same experiment. C) Peak luciferase 
expression from pCS26 plasmids containing the KanR (green), CamR (blue) or TetR (black) antibiotic 
resistance marker in Salmonella Typhimurium cells grown in LB broth at 37° C. Peak luciferase 
expression (measured as counts per second [CPS]) was determined to occur approximately 11.5 
hours into a 48 hour assay. Each bar represents the mean of 32 biological replicates. 
 
  61 
4.2 Preliminary animal trials characterizing the murine transmission model 
4.2.1 The antibiotic marker does not affect the virulence of the Salmonella Typhimurium 
reporter strains in C57BL/6 mice 
We designed the Salmonella Typhimurium reporter strains for use in animal experiments. 
To determine if either the KanR or CamR reporter strains had a significant difference in virulence, 
we designed an experiment where 12 mice were competitively challenged with WT Salmonella  
Typhimurium KanR and CamR reporters containing the sig70-16 promoter controlling luxCDABE 
expression (Figure 13). The challenge inoculum consisted of both strains at an approximately 1:1 
ratio with each mouse receiving 1×106 CFU of each strain. At 5 – 6 days post-infection, the mice 
were euthanized and their organs (spleen, liver, cecum and MLNs) collected, homogenized and 
serially diluted onto LB agar supplemented with 50 µg/mL kanamycin or 10 µg/mL  
chloramphenicol. The number of Salmonella Typhimurium colony forming units from each 
strain was determined for the spleen (Figure 14A), liver (Figure 14B), cecum (Figure 14C) and 
MLNs (Figure 14D). In some individual mice the KanR reporter (green) was recovered at higher 
levels while in other mice the CamR reporter (blue) was recovered at higher levels. Typically, the 
same strain was recovered at higher levels in all organs from a single mouse, suggesting that the 
outcome of the competition between the strains was decided early on in infection, prior to 
systemic dissemination of Salmonella throughout the mouse. If either strain were more virulent 
than the other we would have expected it to be recovered from the majority of the mice at higher 
levels than the other. The final tally showed that the KanR reporter was recovered at higher levels 
in five mice while the CamR reporter was recovered at higher levels in seven mice, suggesting no 
difference in virulence. When we compared the competitive index values for each mouse we saw 
that in none of the organs tested were the competitive index (CI) values significantly different 
than 1 (Figure 14E). The CI values were calculated by comparing the input ratio of the two 
strains at the time of infection of the mice (an approximately 1:1 ratio) and the output ratio of the 
two strains recovered from the mice after infection, based on the CFU numbers recovered from 
each organ. The CI values calculated from each organ were not significantly different from 1, 
which indicated neither strain consistently outcompeted the other. This confirmed that there was 
no significant virulence difference between the KanR and CamR Salmonella Typhimurium 
reporter strains. Therefore, all subsequent animal experiments were performed with the sig70-16 
versions of these KanR and CamR reporter strains 98.  
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Figure 13: Competitive infection of C57BL/6 mice with Salmonella Typhimurium KanR and 
CamR reporters. Twelve female C57BL/6 mice were challenged with a 1x107 CFU, 1:1 challenge of 
both strains. After 5 – 6 days post-challenge mice were euthanized and their organs were harvested 
(liver, spleen, cecum, mesenteric lymph nodes [MLNs]) and homogenized. Homogenized organs were 
plated on selective media to determine bacterial loads of each strain in each organ. 
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Figure 14: Bacterial counts and competitive indices from C57BL/6 mice after competitive 
infection with Salmonella Typhimurium. A to D) CFU counts of Salmonella Typhimurium KanR 
(green) and CamR (blue) reporters recovered from murine organs. Organs were homogenized and 
processed after euthanization and plated on both LB + Kan50 and LB + Cam10 plates to determine the 
levels of each strain present (measured as CFU per whole organ). E) Competitive indices were 
calculated for each mouse in each organ; horizontal lines represent the median in each organ. 
Competitive indices were calculated as follows: ([CFU KanROUT/CFU CamROUT]/[CFU KanRIN/CFU 
CamRIN]). Dotted horizontal line indicates a CI value of 1, representing no difference. Significance was 
determined using a Wilcoxon Signed Rank Test, testing whether each organ was significantly different 
than 1. 
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4.2.2 C57BL/6 mice challenged with Salmonella Typhimurium shed low levels of bacteria in 
their feces 
The main reason for generating the Salmonella reporter strains was for their use in a 
model of murine transmission that we had designed. The model involved the co-housing of both 
infected, seeder mice and naive, uninfected mice. After being infected with Salmonella, the 
seeder mice began shedding bacteria into the cage, causing infection of naive mice. The reporter 
strains were to be used as biological markers that we could monitor and use to track the spread of 
Salmonella throughout the mouse population using a BLI. Unfortunately, the reporters did not 
prove to be successful for this due to the limits in their detection in vivo, but the transmission 
model remained a useful tool. We hypothesized that the main route of transmission in the model 
would be through the fecal-oral route: seeder mice shedding Salmonella in their feces and 
spreading the infection to naive mice through contaminated feces. To determine whether this 
would be a realistic scenario we first needed to determine if mice challenged with Salmonella 
Typhimurium shed bacteria in their feces. We orally challenged ten mice with 1×107 CFU of a 
Salmonella Typhimurium reporter strain; five mice were challenged with the WT and five were 
challenged with the ∆csgD mutant (Figure 15). Each day these mice were isolated and four fecal 
pellets were collected from each individual mouse. These pellets were homogenized and 
processed, then plated on LB media supplemented with either 50 µg/mL kanamycin or 10 µg/mL 
chloramphenicol to recover and quantify the bacteria shed in the pellets.  
Mice challenged with Salmonella Typhimurium shed no detectable bacteria in their feces 
(limit of detection [LoD] = 10 CFU/fecal pellet) until 5 days post-challenge, where they began 
shedding low to moderate levels until their euthanization on day 7 post-challenge (Figure 16). 
On day 5, two mice began shedding low levels of Salmonella, with bacteria counts of 20 and 30 
CFU, respectively, detected in a single fecal pellet. By day 6, four mice were shedding moderate 
amounts of Salmonella in their feces with CFU counts ranging from 20 – 5000 CFU/pellet. On 
day 7 six mice were shedding Salmonella at levels ranging from 10 CFU – 2.6×108 CFU/pellet, 
with only two mice shedding at the high end of the range, while two mice continued to shed no 
detectable bacteria. Despite their variable shedding, all mice displayed severe clinical signs (i.e. 
hunched posture, ruffled fur, listlessness, weight loss >20% of their initial weight) and were 
euthanized by day 7 post-challenge. These results suggested that the majority of mice challenged 
with Salmonella Typhimurium did not shed high levels of Salmonella in their feces, while a  
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Figure 15: Infection of C57BL/6 mice to monitor the levels of Salmonella Typhimurium shedding. 
10 female C57BL/6 mice were challenged with 1x107 CFU of a Salmonella Typhimurium reporter strain 
(either WT or a ∆csgD mutant). Each day individual mice were isolated and 4 fecal pellets were 
collected from each mouse. Fecal pellets were homogenized and plated on selective media to determine 
the levels of shedding. After 5 – 6 days post-challenge mice were euthanized and their organs were 
harvested (liver, spleen, cecum, mesenteric lymph nodes [MLNs]) and homogenized. Homogenized 
organs were plated on selective media to determine bacterial loads in each organ. 
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Figure 16: C57BL/6 mice shed low levels of Salmonella Typhimurium beginning at 5 days post-
challenge. Four fecal pellets shed from mice challenged with WT Salmonella Typhimurium were 
collected and processed daily for 7 days. Each point represents the bacterial load in a single fecal pellet. 
For mice that had no detectable Salmonella in their feces, one data point was used to reduce visual 
clutter. The CFU of Salmonella per individual pellet was determined. The horizontal line represents the 
limit of detection. 
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small subset of the population began shedding high levels of Salmonella 7 days post-challenge. 
A requirement for efficient fecal-oral transmission in our model would be the presence of high 
levels of shedding shortly after infection, to maximize the spread of Salmonella throughout the 
population of mice. The results of this experiment suggested that high shedding levels would be 
achieved only by a small number of mice and only for one or two days before the mice 
succumbed to illness, meaning that they would act as poor carriers of disease. 
4.2.3 Pre-treating C57BL/6 mice with streptomycin leads to increased shedding 
To achieve efficient transmission through the fecal-oral route, a method of inducing high 
levels of fecal shedding needed to be found. Streptomycin pre-treatment had been demonstrated  
to increase the shedding levels in mice that are orally infected with Salmonella 7. To test this in 
our infection model, 20 mice were randomly assigned to four groups; two groups (10 mice) were 
pre-treated with 20 mg of oral streptomycin prior to challenge and two groups were challenged 
similar to the previous experiments. Each individual mouse was challenged with 1×107 CFU of 
WT Salmonella Typhimurium (CamR reporter) and their shedding was monitored over the course 
of the experiment. Four fecal pellets from each streptomycin pre-treated mouse were collected 
daily and processed individually, while four fecal pellets from each untreated mouse were 
collected daily and pooled together in a single tube prior to being processed and plated. This was 
done to ensure that we were able to detect Salmonella in the feces of the untreated mice even 
though our previous experiment had demonstrated that levels in a single fecal pellet were often 
undetectable.  
Similar to the previous experiment the untreated mice had moderate levels of shedding 
throughout the experiment, ranging from approximately 1×102 – 1×105 CFU/g of feces, with two 
samples on day 6 having levels >1×107 CFU/g (Figure 17, grey). This suggested that the mice in 
the previous experiment were shedding low levels of Salmonella throughout the time course that 
were below the level of detection; the pooling of fecal samples in untreated mice resulted in the 
reliable detection of Salmonella. The streptomycin pre-treated group had significantly higher 
levels of shedding throughout the experiment, ranging from approximately 1×107 – 1×1010 
CFU/g of feces (Figure 17, red). In general, the shedding levels appeared to be quite uniform 
over the course of the experiment. Interestingly, for this experiment the streptomycin-treated  
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Figure 17: Pre-treating mice with streptomycin results in significantly higher levels of shedding. 
Four fecal pellets shed from mice challenged with WT Salmonella Typhimurium were collected and 
processed daily for 6 days. Mice were either treated with 20 mg of streptomycin (red) or left untreated 
(grey). Each point from the treated group represents the bacterial load in a single fecal pellet, while each 
point from the untreated group represents the pooled bacterial load from four fecal pellets. The CFU of 
Salmonella per gram of feces was determined. The mean of each group is represented by a black line, with 
standard deviation. The dotted horizontal line represents the limit of detection. Significance (* = p<0.05) 
was determined using multiple t tests. 
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mice had a more rapid disease progression and had to be euthanized at an earlier time point than 
the untreated mice. Pre-treatment with streptomycin significantly increased the shedding levels 
in mice challenged with Salmonella Typhimurium but shortened the length of time that these 
mice would likely be in a cage and spreading infection.  
4.2.4 Initial challenge dose does not affect shedding levels of streptomycin pre-treated 
C57BL/6 mice 
Ideally, mice challenged with Salmonella would be present in a cage with other, naive 
mice for prolonged periods of time in order to maximize their exposure to Salmonella. In an 
attempt to prolong the lifespan of our streptomycin pre-treated mice we lowered the challenge 
dose of Salmonella to observe whether both the shedding patterns and life spans of these mice 
were altered. Three groups of six mice were each challenged with different levels of Salmonella 
Typhimurium (1×104 CFU, 1×105 CFU or 1×106 CFU) (Figure 18). The shedding of the mice 
was monitored over the course of the experiment by collecting and processing 4 fecal pellets 
from each mouse, and over the course of the experiment we monitored the mice’s clinical signs 
to determine if there was a difference in the disease progression between the three groups. The 
shedding levels seen in the mice challenged with the 1×104 CFU challenge (blue), 1×105 CFU 
challenge (green) and 1×106 CFU challenge (red) were determined (Figure 19). Throughout the 
trial, the mean shedding levels of the three groups of mice stayed at approximately 1×109 – 
1×1010 CFU/g of feces, with no significant differences observed. The shedding levels recorded 
were similar to the levels measured in the mice challenged with 1x×107 CFU in our previous 
experiment. This indicated that the challenge dose did not affect the shedding levels observed in 
the mice. This was not unexpected, and had been recorded previously in the literature 7. By day 5 
of the experiment, however, 7 mice had been euthanized with 2 each from the 1×105 CFU and 
1×106 CFU groups and 3 from the 1×104 CFU group. On day 6 all of the remaining mice were 
euthanized due to the onset of severe clinical signs. This suggested that while the challenge dose 
did not alter the shedding levels seen in infected mice it also did not alter the expected lifespan of 
the mice. 
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Figure 18: Testing three challenge levels of Salmonella Typhimurium in streptomycin pre-
treated mice. A total of 18 female C57BL/6 mice – in groups of 6 –  were challenged with WT 
Salmonella Typhimurium after treatment with streptomycin. Six mice were challenged with 1×104 
CFU of Salmonella, six mice with 1×105 CFU of Salmonella and six mice with 1×106 CFU of 
Salmonella. Each day, individual mice were isolated and 4 fecal pellets were collected from each 
mouse. Fecal pellets were homogenized and plated on selective media to determine the levels of 
shedding from the mice. After 5 – 6 days post-challenge mice were euthanized and their organs were 
harvested (spleen, liver, cecum and MLNs) and homogenized. Homogenized organs were plated on 
selective media to determine bacterial loads in each organ. 
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Figure 19: The challenge dose does not alter the shedding or lifespan of C57BL/6 mice. Fecal 
pellets shed from mice challenged with Salmonella Typhimurium were collected and processed 
daily for 6 days. Mice were challenged with 1×104 CFU (blue), 1×105 CFU (green) or 1×106 CFU 
(red). All mice were euthanized on day 6. Each point represents the bacterial load from a single 
fecal pellet, represented as CFU per gram of feces. The mean of each group is represented by a 
black line, with standard deviation. The dotted horizontal line represents the limit of detection. 
Significance was determined using multiple t-tests. 
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4.2.5 WT and ∆csgD Salmonella Typhimurium are shed from and colonize mice at similar 
levels 
As outlined in Section 2.0, we hypothesized that biofilm formation would contribute to 
the transmission success of Salmonella Typhimurium. Therefore, one of the first tests of our 
transmission model would be to compare the transmission efficiencies of both WT Salmonella 
Typhimurium and the isogenic, ∆csgD mutant that is impaired in biofilm formation162. To 
compare the transmission efficiencies of these two strains in our model, we would need to 
monitor their spread throughout a population of mice. If one of the strains were shed from the 
infected seeder mice at higher levels they would likely be spread throughout the cage and into 
the naive, uninfected population at higher rates. This apparent increase in transmission efficiency 
would be due to a difference in shedding levels. Similarly, if one of the two strains were to 
colonize naive mice to a greater extent it would appear as though it had transmitted from the 
seeder mice at higher levels instead of colonizing the naive mice at higher levels. To test these 
two possibilities, we designed an experiment where two groups of six mice were challenged with 
WT Salmonella Typhimurium and two groups of six mice were challenged with the ∆csgD 
mutant; all mice were pre-treated with streptomycin before challenge. To monitor shedding, 
three fecal pellets were collected from each mouse daily and to measure colonization, the organs 
from euthanized mice were collected and processed to determine the bacterial load. Over the 
course of the experiment, mice challenged with either strain displayed the same shedding pattern 
of approximately 1×109 – 1×1011 CFU/g of feces, with no significant differences between groups 
(Figure 20A). Colonization levels were also similar between the different groups of mice, with 
the bacterial load in each type of organ ranging from approximately 1×105 – 1×109 CFU (Figure 
20B). Again, there were no significant differences in colonization between the two strains. These 
results indicated that both WT Salmonella Typhimurium and the isogenic, ∆csgD mutant strain 
colonized and were shed from mice at similar levels when mice were challenged orally with a 
single strain.  
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Figure 20: WT and ∆csgD Salmonella Typhimurium are shed from and colonize mice at similar 
levels. A) Fecal pellets shed from mice challenged with Salmonella Typhimurium were collected and 
processed daily for 5 days. Mice were challenged with WT Salmonella (grey) or with the isogenic 
∆csgD mutant (red). Each point represents the bacteria shed in a single fecal pellet, represented as 
CFU per gram of feces. The mean of each group is represented by a black line, with standard 
deviation. The dotted horizontal line represents the limit of detection. B) Colonization levels from 
mice challenged with Salmonella Typhimurium, represented by the CFU per gram of organ. Mice 
were challenged with WT Salmonella (grey) or with the isogenic ∆csgD mutant (red). Each point 
represents the bacteria in an individual mouse’s organs. The mean of each group is represented by a 
black line, with standard deviation. The dotted horizontal line represents the limit of detection. 
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4.3 Analysis of fecal survival and recovery of Salmonella Typhimurium 
4.3.1 WT Salmonella Typhimurium have greater short-term survival potential in fecal 
pellets 
Previous studies had shown that cellular aggregation and biofilm formation in Salmonella 
were not virulence adaptations 151, suggesting that these physiologies played a role in another 
aspect of the Salmonella life cycle. Due to a large body of work examining the resistance 
properties of biofilms, we hypothesized that cellular aggregation could be involved in the 
environmental persistence and survival of biofilm-associated cells. To test this we challenged 
streptomycin pre-treated mice with either WT Salmonella Typhimurium or the ∆csgD mutant 
and collected fecal pellets from these mice daily (Figure 21). The fecal pellets were stored in 96-
well plates after collection and left to dry at room temperature and in direct light to mimic 
environmental conditions. Each week, 6 – 10 fecal pellets from each strain were randomly 
selected, processed and plated on LB agar supplemented with antibiotics to determine the levels 
of Salmonella that could be recovered from the pellets after long-term storage.  
On day 0 (the day of collection) there was no significant difference in the recovery levels 
of either strain, with levels of approximately 1×108 CFU/fecal pellet (Figure 22). After one week 
of storage we observed that the WT strain was recovered from fecal pellets at significantly 
higher levels than the ∆csgD mutant, suggesting it was better able to persist inside of these fecal 
pellets. After 2 weeks we observed the same general trend with WT cells recovered at generally 
higher levels; however, the results lost significance (p = 0.053), likely due to the presence of a 
few outliers. The same general trend was present after 3 weeks. From 4 – 6 weeks the trend 
disappeared, with both the WT and ∆csgD mutant cells recovered at a large range of levels and 
with no significant differences between the two groups. The results demonstrated that WT 
Salmonella Typhimurium had higher survival potential than the ∆csgD mutant in the short term 
(a period of 1 – 2 weeks) under environmental conditions when shed in fecal pellets. 
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Figure 21: Testing the survival potential of WT and ∆csgD Salmonella Typhimurium. Female 
C57BL/6 were challenged with either WT or ∆csgD Salmonella Typhimurium after treatment with 
streptomycin. Each day individual mice were isolated and fecal pellets were collected from each mouse. 
These fecal pellets were stored in 96-well plates in direct light and at room temperature. Each week 6 – 
10 fecal pellets were randomly selected, homogenized and plated on selective media to determine the 
levels of each strain that could be recovered.  
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Figure 22: WT Salmonella Typhimurium have greater short-term survival potential in fecal 
pellets. Fecal pellets shed from mice challenged with Salmonella Typhimurium were collected and 
processed weekly for 6 weeks. Fecal pellets were shed from mice challenged with WT Salmonella 
(grey) or the isogenic ∆csgD mutant (red). On day 0 four fecal pellets from each group were sampled, 
on weeks 1 – 4 six fecal pellets from each group were sampled and on weeks 5 – 6 10 fecal pellets 
from each group were sampled. Each point represents the bacteria recovered from a single fecal pellet. 
The mean of each group is represented by a black line, with standard deviation. The dotted horizontal 
line represents the limit of detection of 100 CFU/pellet (weeks 0 – 3) or 10 CFU/pellet (weeks 4 – 6). 
Significance (*) was determined by multiple t tests (p value <0.05). 
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4.3.2 Fresh fecal pellets allow for the recovery of higher levels of Salmonella Typhimurium 
To maximize the number of fecal pellets we could test in future Salmonella survival 
experiments we collected fecal pellets in large quantities. Two groups of mice pre-treated with 
streptomycin were challenged with either WT Salmonella Typhimurium or the ∆csgD mutant 
and monitored over the course of the experiment. Instead of isolating each mouse and collecting 
fecal pellets daily, we moved the mice to new cages each day and collected all the fecal pellets 
shed into the cage over the previous day. Typically, we collected 96 fecal pellets (one 96-well 
plate) of each strain daily during the course of the experiment. The shedding levels we observed 
using this method (Figure 23; July and August) were significantly lower than the levels of 
shedding seen in previous trials (Figure 23; March). In our previous experiments, for the first 
three days post-challenge we measured shedding of approximately 1×109 CFU/g of feces, while 
the two mass collection experiments resulted in levels ranging from 1×105 – 1×108 CFU/g, with 
the recovery from some individual fecal pellets near the LoD of 10 CFU/g. It was clear that the 
recovery of Salmonella from fecal pellets in bulk was different than our initial experiment. We 
hypothesized that the variable period of time of up to one day that fecal pellets sat in a cage prior 
to being processed could account for the reduction in recovery levels from these fecal pellets.  
To test if there was a difference in CFU recovered between fresh (collected and processed 
immediately) and desiccated (collected and processed up to one day post-shedding) fecal pellets, 
we designed an experiment to compare the recovery of Salmonella from both. Similar to the 
previous experiment, mice were challenged with either WT Salmonella Typhimurium or the 
∆csgD mutant after pre-treatment with streptomycin, and fecal pellets were collected from the 
cage each day. We also collected three fresh pellets from two randomly selected mice per cage in 
order to compare these levels to the desiccated pellets (Figure 24). After processing, we observed 
that the fresh pellets (red) resulted in significantly higher recovery levels of Salmonella 
Typhimurium than desiccated pellets (grey) for the duration of the experiment. We were unable  
to collect fresh pellets from the mice on day 5 due to the progression of disease. Fresh fecal 
pellets collected in this trial resulted in Salmonella recovery levels of approximately 1×106 – 1 
×107 CFU/pellet, similar to the levels observed in previous trials. In contrast, the desiccated fecal 
pellets resulted in recovery levels of approximately 1×104 – 1 ×105 CFU/pellet, which were 
similar to those seen in the July and August trials (Figure 23). Considering that both groups of 
fecal pellets were collected from the same groups of mice, it appeared that a period of  
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Figure 23: Mass collection leads to reduced recovery of Salmonella Typhimurium in fecal pellets. 
Fecal pellets shed from mice challenged with Salmonella Typhimurium were collected and 6 pellets 
per cage were processed daily for 5 days to monitor the shedding levels. WT and ∆csgD data has been 
pooled together. Data from a previous experiment (March; blue) was compared to a new method for 
the mass collection of pellets (July and August; green and red). Each point represents the bacteria shed 
in a single fecal pellet, represented as CFU per gram of feces. The mean of each group is represented 
by a black line, with standard deviation. The dotted horizontal line represents the limit of detection.  
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Figure 24: Fresh fecal pellets allow for significantly higher recovery of Salmonella 
Typhimurium. Fresh and desiccated fecal pellets shed from mice challenged with Salmonella 
Typhimurium were collected and 6 pellets of each type per cage were processed daily for 5 days to 
monitor the recovery of Salmonella. WT and ∆csgD data was pooled together. The recovery of 
Salmonella from fresh fecal pellets (red) was compared to the recovery from desiccated fecal 
pellets (grey). Each point represents the bacteria recovered from a single fecal pellet, represented 
as CFU per pellet. The mean of each group is represented by a black line, with standard deviation. 
The dotted horizontal line represents the limit of detection of 10 CFU/pellet. Significance (*) was 
determined by multiple t tests (p value <0.05). 
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desiccation of ≤1 day was sufficient to significantly reduce the recovery levels of Salmonella 
from fecal pellets. 
4.4 Testing the transmission potential of WT and ∆csgD Salmonella Typhimurium 
4.4.1 C57BL/6 seeder mice can transmit Salmonella Typhimurium infection to naive mice 
pre-treated with streptomycin 
To begin testing the transmission potential of different strains of Salmonella 
Typhimurium we first needed to test if transmission from infected seeder mice to uninfected 
naive mice could occur. Our first experiment involved challenging seeder mice with Salmonella 
Typhimurium, co-housing them with naive mice and monitoring the spread of infection (Figure 
25). Mice were randomly assigned to three groups with each group consisting of two seeder mice 
and five naive mice. The seeder mice were pre-treated with streptomycin and challenged with 
1×105 CFU of WT Salmonella Typhimurium prior to co-housing. After challenge, the seeder 
mice were co-housed with the naive mice, with each group of naive mice manipulated in a 
different manner. Naive mice in group 1 were co-housed with the seeder mice and not 
manipulated, naive mice in group 2 were pre-treated with streptomycin – in the same manner as 
the seeder mice – prior to co-housing, and naive mice in group 3 were fasted for 16 hours prior to 
and 4 hours after co-housing in order to increase the chance of coprophagy. The clinical signs of 
the mice were monitored to track the spread of Salmonella infection; when naive mice began 
showing signs of infection transmission was deemed to have occurred. 
At 10 days post-challenge, all mice were euthanized and their organs were collected and 
processed to determine whether Salmonella had transmitted from the infected mice to naive 
mice. All seeder mice were colonized successfully with Salmonella (Figure 26); each of these 
mice had been euthanized 4 to 5 days post-challenge. However, out of the three groups of naive 
mice, only mice in group 2 had detectable colonization with Salmonella. All naive mice from 
group 2 (streptomycin pre-treated) had high levels of Salmonella recovered from their organs,  
similar to the levels seen in the seeder mice. None of the naive mice from groups 1 (no 
manipulation) and 3 (fasted) had detectable Salmonella in any of their organs even though the 
seeder mice co-housed with these groups were all infected and shedding high levels of 
Salmonella into the cages. Looking at the transmission efficiency of the seeder mice (the 
percentage of naive mice infected with Salmonella) we observed that seeder mice in group 2 had  
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Figure 25: Testing the transmission potential of seeder mice challenged with Salmonella 
Typhimurium. Six female C57BL/6 were challenged with 1×105 CFU of Salmonella Typhimurium after 
treatment with streptomycin. Seeder mice were split into 3 groups of 2, with each group containing 5 naive 
mice. Group 1 was not manipulated. Group 2 naive mice were pre-treated with streptomycin before the 
addition of seeder mice. Group 3 naive mice were fasted for 20 hours (16 hours pre-mingling and 4 hours 
post-mingling) to promote coprophagy. The clinical signs of all mice were checked daily to monitor any 
transmission from the seeder mice to the naive mice. Mice were euthanized after the appearance of severe 
clinical signs (weight loss of >20%) or 10 days post-mingling and their organs were homogenized and 
processed to determine whether Salmonella had been transmitted. 
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Figure 26: Seeder mice can transmit Salmonella to naive mice pre-treated with streptomycin. After 
collection all organs were processed and plated on selective media to determine whether Salmonella had 
been transmitted. Seeder mice are marked S1 – S6 while naive mice are marked 1 – 15, and were 
divided into 3 groups. The levels of Salmonella in their organs (spleen [blue], liver [red], cecum [green] 
and MLNs [grey]) were tested. Mouse 9 was found dead in its cage overnight and no organ counts were 
determined. Transmission efficiency was calculated as the percentage of naive mice in each group with 
detectable levels of Salmonella in any organ. 
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a transmission efficiency of 100% while seeder mice in groups 1 and 3 had a transmission 
efficiency of 0%. The presence of an intact gut microbiota likely had a strong influence on 
whether or not transmission occurred in these mice. 
4.4.2 Developing a working model of transmission for Salmonella Typhimurium in 
C57BL/6 mice 
Based on the data we had collected up to this point, we thought we could design a 
standard transmission experiment (Figure 27). This model would consist of seven mice co-
housed in a single cage: two seeder mice that were infected with Salmonella and five naive mice 
who remained uninfected. All of the naive mice would be pre-treated with streptomycin. Such a 
model would allow us to compare the transmission efficiencies of both the WT strain and the 
mutant strain and compare whether this mutation had a significant effect on transmission. If the 
mutant experienced a reduction in transmission efficiency, it could be inferred that the gene in 
question played a role in the transmission cycle of Salmonella. 
Experiments based on this model were divided into two general groups: experiments 
examining short-term transmission and experiments examining long-term transmission (Figure 
28). This differentiation was made in an attempt to probe two different aspects of transmission in 
a model resembling a real-world environmental scenario. Short-term transmission was primarily 
focused on the direct, host-to-host transmission of infection from seeder mice to naive mice 
through the fecal-oral route. The seeder mice, once infected with Salmonella, shed bacteria into 
the cage at high levels and naive mice would be exposed to these bacteria after a short period of 
time and become infected with Salmonella. Long-term transmission was focused on a prolonged 
environmental stage, such as fecal pellets that were shed into the environment and were 
encountered by naive mice after a significant period of time. The stage between shedding of the 
bacteria and encountering another host would involve numerous environmental stresses and 
potentially require a more specialized subset of genes to maximize the transmission potential of 
Salmonella. 
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Figure 27: Overview of transmission model. The transmission model we designed involved two seeder 
mice co-housed in a cage with five naive mice. One seeder mouse would be challenged with WT 
Salmonella Typhimurium and the other with the mutant strain being tested. Over time, the seeder mice 
would shed Salmonella in their feces and expose the naive mice to infection. If the mutant strain was 
defective in an aspect of the transmission pathway it would be expected that it would transmit to fewer 
mice than the WT, or at lower levels. By euthanizing the mice and processing their organs we would be 
able to observe any differences in transmission efficiencies between the two strains. 
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Figure 28: Distinction between short- and long-term transmission pathways in our model. To test 
transmission in both short- and long-term scenarios, we tested different transmission pathways. Short-
term transmission was the result of direct transmission from seeder mice, with contaminated fecal pellets 
shed into the cage and naive mice exposed to Salmonella. It represented a more direct transmission 
pathway, with little environmental influence. Long-term transmission attempted to more accurately 
represent environmental transmission. Fecal pellets shed from seeder mice five weeks previously were 
desiccated and added to a cage containing naive mice. The long-term desiccation step put environmental 
pressure on the bacteria in the fecal pellets before they could be transmitted to naive mice. 
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4.4.3 Salmonella Typhimurium ∆csgD is not impaired in short-term transmission efficiency 
To test the short-term transmission potential of WT Salmonella Typhimurium and the 
biofilm-negative ∆csgD mutant we performed an experiment comparing both strains’ ability to 
transmit to naive mice (Figure 29). Four groups of mice – each consisting of two seeder mice and 
five naive mice – were pre-treated with streptomycin and co-housed. The seeder mice were 
challenged with 1×105 CFU of Salmonella Typhimurium prior to co-housing; two groups had 
seeder mice that were challenged with WT Salmonella and two groups had seeder mice that were 
challenged with the ∆csgD mutant. Reciprocal challenges were performed, with one cage 
receiving KanR WT Salmonella Typhimurium and another cage receiving CamR WT Salmonella 
Typhimurium (and the same with the ∆csgD mutant) to ensure there were no differences in 
transmission due to the different antibiotic resistance markers. This design also allowed us to 
perform the experiments with blinding, so that we did not know which cage received each strain. 
After co-housing, the naive mice were monitored for the onset of clinical signs, which indicated 
the transmission of infection. At the conclusion of the experiment all of the mice were 
euthanized and their organs were processed to determine if they had been infected with 
Salmonella Typhimurium. 
At 7 days after co-mingling, the naive mice from all four groups had become ill and were 
euthanized; infection with Salmonella Typhimurium was confirmed after their organs were 
collected and processed (Figure 30A). This indicated that both WT and ∆csgD Salmonella 
Typhimurium had 100% short-term transmission efficiency in this model, and were able to 
transmit to all of the naive mice in a cage. Interestingly, the Salmonella colonization levels of 
naive mice infected through the fecal-oral route were similar to those seen in seeder mice, 
suggesting that the route of infection did not affect the total colonization levels of Salmonella. 
The spread of infection throughout the mouse population was monitored through the weight loss 
of naive mice. After becoming infected with Salmonella the disease caused rapid weight loss 
until a point when the mice were euthanized. The weight loss of the naive mice is displayed with 
the critical point of 20% of initial weight lost represented as a dotted line (Figure 30B). Naive 
mice that were co-housed with WT-infected seeder mice (grey) generally experienced weight 
loss beginning at day 4 and underwent a gradual decline until day 7 when they were euthanized. 
One mouse from this group began rapidly losing weight on day 3 and did not recover, leading to 
its euthanization early on day 5. Naive mice that were co-housed with ∆csgD -infected seeder  
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Figure 29: Testing the short-term transmission potential of WT and ∆csgD Salmonella 
Typhimurium. 8 female C57BL/6 were pre-treated with streptomycin and challenged with 
Salmonella Typhimurium – 4 mice with the WT and 4 with the ∆csgD  mutant. These seeder mice 
were split into 4 groups of 2, with each group containing 5 naive mice. The clinical signs of all mice 
were checked daily to monitor any transmission from the seeder mice to the naive mice. Mice were 
euthanized after the appearance of severe clinical signs (weight loss of >20%) and their organs were 
homogenized and processed to determine whether Salmonella had been transmitted. 
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Figure 30: Salmonella Typhimurium ∆csgD is not impaired in short-term transmission. A) 
Colonization levels of naive mice infected with Salmonella, represented as CFU per gram of organ. 
Naive mice were co-housed with seeder mice challenged with either WT (grey) Salmonella 
Typhimurium or the isogenic ∆csgD mutant (red), and the colonization levels of Salmonella in their 
organs were examined after euthanization. Each point represents the bacteria in an individual mouse’s 
organs. The mean of each group is represented by a black line, with standard deviation. The dotted 
horizontal line represents the limit of detection. B) Weight loss of the naive mice was tracked over the 
course of the experiment as a measure of the percentage of initial weight lost. Mice were housed with 
wild-type infected seeders (grey) or ∆csgD infected seeders (red) and their weight loss was monitored 
over the course of the experiment. The line at 80% represents severe weight loss of 80%, which is the 
point at which mice must be euthanized. 
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mice (red) experienced a similar weight loss trend, with most beginning to lose weight at day 4 
post-mingling and trending downwards until day 7 and euthanization. Two of these mice 
experienced rapid weight loss on day 3, but were able to recover slightly until euthanization on 
day 7. Together this data suggested that there was no difference in the speed of transmission 
between the two strains, as well as no deficiency in overall short-term transmission by the ∆csgD 
mutant. 
4.4.4 Salmonella Typhimurium ∆csgD is not impaired in long-term transmission efficiency 
To test if the ∆csgD mutant was instead deficient in long-term transmission we designed 
a similar experiment examining both strains’ ability to transmit to naive mice from desiccated 
fecal pellets (Figure 31). The idea underlying this experiment was that while both WT and 
∆csgD Salmonella Typhimurium were able to transmit at high efficiencies in the short-term, the 
biofilm-related processes and survival advantages of the WT may play a larger role after a period 
of imposed long-term environmental persistence and survival. In introducing long-term storage 
and desiccation of the fecal pellets, we attempted to mimic a long-term scenario where 
Salmonella would be shed into the environment in fecal matter and persist for a long period of 
time prior to encountering a new host. The experiment therefore involved two groups of naive 
mice, each pre-treated with streptomycin. Each cage was seeded with 200 fecal pellets (100 WT 
pellets and 100 ∆csgD pellets) that were shed from Salmonella-infected seeder mice 5 weeks 
previously; the pellets had been placed in 96-well plates and stored at room temperature with 
exposure to direct light. Two groups of five naive mice that had been pre-treated with 
streptomycin were in the cages and monitored for the onset of clinical symptoms of Salmonella 
infection. 
In the first 10 days, four mice became infected with Salmonella (Figure 32A). Two of 
these mice were euthanized prior to their death (318N and 318L), while two mice were found 
dead overnight (317L and 3182R). The organs from the euthanized mice were collected and 
processed, while only the livers from the dead mice could be recovered. Both of the euthanized 
mice and one of the dead mice were highly colonized with the ∆csgD mutant strain of 
Salmonella, with low levels of the WT strain in some organs. The remaining dead mouse was 
highly colonized with the WT strain and had undetectable levels of the ∆csgD mutant. We  
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Figure 31: Testing the long-term transmission potential of WT and ∆csgD Salmonella Typhimurium. 
2 groups of 5 naive mice were put into cages after treatment with streptomycin and exposed to fecal pellets 
contaminated with Salmonella Typhimurium. Each cage was seeded with 100 fecal pellets containing WT 
Salmonella and 100 fecal pellets containing Salmonella ∆csgD that had been desiccated for a period of 5 
weeks. The clinical signs of all mice were checked daily to monitor any transmission from the fecal pellets 
to the naive mice. Mice were euthanized after the appearance of severe clinical signs (weight loss of 
>20%) or after a period of 14 days, and their organs were homogenized and processed to determine 
whether Salmonella had been transmitted. 
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Figure 32: Salmonella Typhimurium ∆csgD is not impaired in long-term transmission. After 
euthanization the organs from all mice were processed and plated on selective media to enumerate the 
numbers of Salmonella present. A) Four mice became infected with Salmonella in the first 10 days 
and were euthanized (318N and 318L) or found dead in their cages (317L and 3182R; only the livers 
from these mice could be recovered). B) After 14 days the remaining mice were euthanized. The levels 
of Salmonella in each organ were examined. The dotted horizontal line represents the limit of 
detection. 
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allowed the experiment to proceed for four additional days. At 14 days post-seeding, although 
the remaining six mice showed no outward signs of infection, they were euthanized and their 
organs were examined for Salmonella colonization. We recovered Salmonella from five of the 
six mice. Three mice (317NM, 317B and 3172R) were colonized with the ∆csgD mutant, with no 
detectable levels of the WT strain, whereas two mice (318R and 318B) were colonized with the 
WT and had no detectable levels of the ∆csgD mutant (Figure 32B). One mouse (317R) 
remained uninfected with either strain. The colonization levels in the five mice with detectable 
Salmonella were lower than the four mice in the first 10 days of the experiment, suggesting it 
was possible that their infections would have progressed to symptomatic disease and death if 
given more time. Overall, the WT strain infected three mice at high levels while the ∆csgD 
mutant infected six mice at high levels. Though taken from a small group of mice, these results 
suggested that the ∆csgD mutant was not deficient in long-term transmission, as tested in our 
model.
93 
5.0 DISCUSSION, FUTURE WORK AND CONCLUSIONS 
5.1 Discussion 
Though unsuccessful at demonstrating the role of Salmonella biofilm formation in the 
transmission process (through the mechanism of CsgD regulation of biofilm formation) our 
transmission model laid the foundation for future studies. Subsequent studies could attempt to 
assign roles to specific genes that are predicted to be involved in the transmission process. The 
model was well characterized over the course of this study and allows for modifications to be 
made at later stages to adapt to the needs of subsequent experiments. We were also successful in 
engineering a small library of Salmonella Typhimurium reporter strains for use in our 
experiments, and assembled a Tn7 transposition system to facilitate the generation of a large 
variety of further reporters. The reporters themselves could be used to detect Salmonella both in 
vitro and in vivo in streptomycin pre-treated mice, and potentially in future transmission 
experiments after further characterization of their luciferase expression in vivo. Regardless of 
their use in vivo, the Tn7 system we generated has numerous applications for in vitro 
experiments; the ease of promoter swapping allows for rapid comparisons of gene expression 
using a luminometer. 
The modified Tn7 system we designed allows for the rapid and straightforward 
construction of various reporters in many bacterial species. The pUC18R6KT-miniTn7T delivery 
vector contains a R6K origin of replication, which means that its replication is supported in many 
bacterial species containing the pir gene 26,118. Tn7 transposition using our system could therefore 
be used in many different species to generate a diverse library of reporters. The requirement of 
the pir gene also allows for its successful use as a suicide vector, ensuring that it is cured from 
the cell after transposition. Tn7 transposition using the pUC18R6K miniTn7T vector had 
previously been successfully demonstrated in P. aeruginosa, Y. pestis and B. thailandensis, 
establishing its utility in a variety of bacterial species 26. Prior to using this method, we attempted 
to use another system utilizing a single plasmid-based system 101 but did not have success in 
Salmonella Typhimurium, despite the authors stating its successful use. The vector (pGRG25) 
contained a pSC101 origin of replication, suggesting that its replication would be supported in 
Salmonella. Ligation of our reporter construct proved to be difficult, possibly due to the large 
size of both our construct (~8 kb) and the vector itself (~12.5 kb), though the authors had 
confirmed the successful transposition of the lux operon using the pGRG25 vector 101. Once we 
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had successfully ligated our construct into the vector, we were unable to initiate transposition in 
the recipient Salmonella Typhimurium cells, even after optimizing the expression of the 
tnsABCD operon from the PBAD promoter (i,e. glucose concentration in the media).  
The reporters that we constructed had similar yet not identical levels of luciferase 
expression depending on the orientation of the reporter construct (Figure 4A). Both the forward 
and reverse constructs were genetically identical and were inserted into the chromosome at 
identical sites, yet reporters with the construct in the reverse orientation had elevated luciferase 
expression. This could be due to slight differences in promoter recognition or efficiency of 
translation due to the change in reporter orientation, shifting the spatial location of sites on the 
chromosome. We were unable to determine the cause of the slight differences in expression, and 
decided not to pursue the cause of this effect. We found that the KanR and CamR luciferase 
constructs had different levels of luciferase expression when expression was compared in either 
the pCS26 vector or in the chromosomal reporters (Figures 5A, 8D and 9B/D). The Salmonella 
Typhimurium KanR reporters had elevated levels of luciferase expression compared to the CamR 
reporters, suggesting that the resistance marker or growth in the presence of kanamycin or 
chloramphenicol affected the expression of luciferase from these reporters (Figure 5A). When 
the expression of the various pCS26 reporter constructs was compared we observed that the 
CamR vectors had significantly lower levels of expression in Salmonella (Figure 9B). 
Furthermore, the expression of both the sig70c10 and sig70c35 promoters was similar in the 
CamR vector regardless of the promoter, with expression that plateaued at similar peak levels. 
When we took the same reporter constructs and inserted them into the Salmonella Typhimurium 
chromosome we saw that there was no difference between the KanR and CamR reporters with the 
sig70-16 and sig70c10 promoters (Figure 9D). The KanR and CamR sig70c35 promoters 
remained significantly different. The apparent loss of significant differences between the 
differentially marked reporter constructs from vector to chromosome in Salmonella could 
possibly be due to complications caused by the growth of Salmonella in chloramphenicol, which 
has been shown to interfere with various cellular processes through the upregulation of cellular 
proteases triggered by the overproduction of chloramphenicol acetyltransferase 56. In contrast, we 
observed that the CamR vector in E. coli had significantly elevated luciferase expression 
compared to the KanR vector, suggesting that this was a Salmonella-related phenomenon (Figure 
8D). Differences in σ70-regulated promoter expression or polymerase transcription in E. coli and 
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Salmonella could explain the differences observed. Overall, these results suggest that 
quantitative comparisons of luciferase expression between KanR and CamR reporters is not 
possible at this time until these differences are characterized in greater depth. 
Using the Tn7 transposition system and by introducing slight modifications to the 
promoter regions we were able to generate a suite of reporters with three levels of luciferase 
expression. Most importantly, we were able to generate this suite of reporter expression by 
altering only one or two nucleotides in the -10 or -35 regions of the sig70-16 promoter, bringing 
either of these regions to the σ70 consensus sequence (Figure 8A). These small nucleotide 
changes resulted in expression that increased by up to 10 times in vitro and almost 100 times in 
vivo. The expression dynamics of the luciferase operon downstream of these promoters remained 
the same, demonstrating that only the magnitude of expression was altered (Figures 8C and 
9A/C). The increased expression from these promoters resulted in somewhat better detection of 
luciferase in vivo in mice pre-treated with streptomycin, as well as in the organs of these mice 
after euthanization (Figure 10). Unfortunately, the increased magnitude of luciferase expression 
did not increase the detection of these reporters beyond one-day post-challenge and prior to the 
onset of clinical signs. Our original intention with these reporter strains was to design a model of 
transmission that would use the reporters to track the spread of Salmonella in our mouse 
population. Ultimately, we hoped that we would be able to detect our Salmonella reporters using 
a BLI prior to the onset of clinical signs in our mice and better gauge the time of transmission; in 
practice our reporters were not detectable with enough accuracy and precision in most cases, 
regardless of the magnitude of expression. This could have been due to intrinsic factors like the 
absorption of bioluminescence by animal tissues or other factors affecting the bioluminescence 
of our reporters. The emission of bioluminescence is optimal in an aerobic environment, and the 
intestinal tract is largely anaerobic 50; this could explain why the reporters were detected early on 
after infection, when they had been recently exposed to an aerobic environment. Once 
Salmonella had reached levels high enough to cause severe clinical signs in an animal, the 
bacterial burden could have been high enough to overcome an emission threshold of detection. It 
has also been demonstrated that certain in mammalian tissues, hemoglobin absorbs a significant 
amount of bioluminescence at wavelengths shorter than 600 nm 23,149. The bacterial luciferase we 
utilized in our reporter strains produced a primary luminescence peak at 490 nm as well as a 
secondary peak at 590 nm, which could also help explain why their detection was limited in vivo 
  96 
until a certain threshold was reached. Finally, the spatial position of each organ in the murine 
body as well as the position of a mouse on the imaging platform affects the ability to detect 
luciferase in a mouse using a BLI 23. It remains a possibility that slight differences in the organ 
depths of individual mice could result in non-uniform detection efficiencies of our reporter 
strains in vivo. 
 The differentially marked KanR and CamR reporter strains had similar virulence levels 
when tested in C57BL/6 mice (Figure 14). A large difference in the virulence of the two strains 
would have appeared as a large difference in the number of mice colonized by each strain, and 
CI values significantly different than 1. Each strain was represented at high levels in a similar 
number of mice (5 KanR vs. 7 CamR; Figures 14A – D), and the competitive index values we 
calculated were not significantly different than 1 in any of the organs we sampled (Figure 14E). 
It also appeared that each mouse had a dominant strain that was present in each of its organs, 
suggesting that the outcome of the competition between the strains was decided early on in the 
infection and that this strain colonized each organ at a higher level.  
 When mice were challenged with our reporter strains without streptomycin treatment, we 
saw very little shedding from these animals (Figure 16). No Salmonella was detected for the first 
four days of the experiment, and on day 5 only low levels were seen. This was similar to the 
results seen in previous studies, where C57BL/6 mice challenged with 1×108 CFU of Salmonella 
Typhimurium SL1344 had very low shedding levels on days 1 and 2 post-challenge7. Salmonella 
Typhimurium infection in untreated mice typically results in a systemic infection with few of the 
hallmarks of human gastroenteritis, and a lasting, chronic infection in resistant (Slc11α1+) mice. 
Susceptible (Slc11α1-) mice, such as C57BL/6 mice, typically experience an acute, systemic 
infection. The absence of fecal shedding until the later stages of infection was therefore not 
surprising. Streptomycin treatment of mice results in pathology that more closely resembles 
gastroenteritis, with intestinal inflammation and high levels of shedding. The subsequent 
treatment of mice with streptomycin in our model followed the paradigms that had been 
established previously. C57BL/6 mice that had been pre-treated with a single 20 mg oral dose of 
streptomycin shed Salmonella in the range of 1×107 – 1×1010 CFU/fecal pellet (Figure 18) as 
reported in the literature 7. Histology of the mice used in our experiments was not performed, but 
macroscopic analysis of the ceca confirmed earlier reports that the cecum in mice treated with 
streptomycin became “shriveled to a small size, pale and filled with purulent exudate” 7. We also 
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observed that the initial inoculum dose did not impact the final shedding levels and colonization 
levels (Figure 20), as previously reported 82. That the challenge dose did not impact the 
colonization and life expectancy of the mice was not surprising; streptomycin treatment has been 
shown to increase the colonization potential of Salmonella and significantly reduce the oral 50% 
infectious dose in mice 7. This treatment is thought to result in a transient disruption of the 
colonization resistance of mice, resulting in fast and efficient colonization by Salmonella 7,53. 
Such a large perturbation in the microbiota of these mice would allow for a significantly smaller 
Salmonella challenge to colonize to similar levels as a larger challenge. 
 Mice challenged with either WT or ∆csgD Salmonella Typhimurium were colonized by 
and shed bacteria at the same levels (Figure 20). This suggested that the ∆csgD mutation was not 
impacting the ability of Salmonella to colonize and be shed from a host, at least when challenged 
in isolation. CsgD has been implicated in many different biofilm-related processes, as it is a 
transcription regulator regulating many of the pathways involved in the production of the 
components of the biofilm matrix 54. One limitation of this experiment was that each infection 
was done in isolation: a mouse was challenged with either the WT or the ∆csgD mutant. Recent 
work in our lab has shown that when WT and ∆csgD Salmonella Typhimurium are given as 
competitive infections in C57BL/6 mice, the WT bacteria displayed a significant virulence 
advantage 98. The ∆csgD mutant was also demonstrated to have depressed expression levels of 
different SPI-I genes, such as the effectors sipD and spoE2, when compared to WT planktonic 
cells. This suggests that CsgD may play an as of yet unknown regulatory role in Salmonella 
virulence, potentially through regulation of SPI-I-associated virulence, and that any future work 
comparing the transmission of WT and ∆csgD Salmonella Typhimurium would need to be done 
using each strain in isolation.  
 Biofilm formation and cellular aggregation have been associated with environmental 
survival and persistence in previous studies due to the increased survival in many environmental 
conditions they bring. We tested the ability of WT and ∆csgD Salmonella Typhimurium (strains 
that both aggregated and did not, respectively) to survive in the environment after being shed 
from a host (Figure 24). We observed that WT Salmonella had a significant advantage over the 
∆csgD mutant after one week of desiccation and storage, while the difference in recovery was 
lost after this period of time. After one week there was a significant drop in the recovery of both 
cell types, but the WT cells were recovered at significantly higher levels than the ∆csgD mutant. 
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After week 3, the recovery of both cell types became quite sporadic, resulting in some pellets 
with high CFU counts and some pellets with extremely low CFU counts. The ∆csgD mutant in 
particular had a significant increase in the levels recovered after week 2. It is possible that this 
was due to the large variability in the recovery levels of bacteria from fecal pellets. The range of 
cell counts we observed in fecal pellets was typically anywhere from 1×107 CFU/g to 1×1011 
CFU/g (Figure 19). If a pellet was collected and stored and contained bacteria at the high end of 
the range it would be expected to result in the recovery of more bacteria at week 4 than pellets 
that contained bacteria at the low end of the range. The large variability in the levels of 
Salmonella in each individual fecal pellet could explain the variability in the recovery of bacteria 
after a period of 6 weeks. 
 We observed that a period of ≤ one day was sufficient to reduce the recovery of 
Salmonella in feces (Figures 23 and 24). Though cages were changed each day and all fecal 
samples collected and processed that day, the period between shedding and processed resulted in 
a significant decrease in the levels of Salmonella recovered from these fecal pellets. We had 
observed previously that a period of one week was sufficient to result in a drop in the recovery of 
Salmonella (Figure 22), but did not expect the same drop in recovery after less than one day. 
Clearly the short period of time after exiting a murine host exerts strong environmental pressures 
on Salmonella, resulting in the drop in recovery we observed. 
 We determined that the transmission of Salmonella Typhimurium from infected to naive 
C57BL/6 mice was possible if the naive mice were pre-treated with streptomycin (Figure 26). 
Transmission through this method was highly efficient, with all of the naive mice becoming 
infected and colonized with Salmonella. This had previously been demonstrated in 129X1/SvJ 
mice in a chronic Salmonella infection model 94, but to our knowledge this was the first acute 
infection model of Salmonella transmission. According to this model, the majority of the mice in 
our model would be termed moderate shedders or supershedders, shedding between 1×107 – 
1×1011 CFU/g feces. Pre-treating the mice in our model with streptomycin essentially converted 
all of the mice to supershedders, ensuring highly efficient transmission. Mice that were fasted for 
20 hours and mice that were not manipulated had undetectable levels of Salmonella in their 
organs, suggesting that transmission did not occur. In our transmission experiments we 
monitored the spread of Salmonella through CFU counts quantifying the colonization of the 
spleen, liver, cecum and MLNs of naive mice, as well as observing their clinical signs. It is 
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possible that this was not sensitive enough to detect transmission in some mice, or that a period 
of 14 days was not sufficient for transmission to occur in all scenarios. Other groups have looked 
for the presence of Salmonella-specific intestinal IgA and IgG 94, TNF-α and IL-1β in mice 
colonized by P. aeruginosa 83 and other immunological markers as indicators of transmission, 
and it is possible that using criteria such as these would result in a more sensitive detection of 
transmission. Our original intent was to monitor the transmission of Salmonella using the 
reporter strains we had generated. As Salmonella spread to mice, we had hoped to observe 
luminescence in naive mice before the onset of clinical signs, giving us a better view of 
transmission. Our reporters were not sensitive enough to facilitate these types of studies, which is 
why we used clinical signs and colonization levels as indicators of transmission. It may be useful 
in the future to confirm that transmission in this model occurs through the fecal-oral route. An 
experiment where the mice are separated from fecal pellets as they are shed (i.e. with raised 
mesh flooring) would be simple to perform; if transmission rates dropped, it would suggest that 
access to fecal pellets is required for optimal transmission, confirming the fecal-oral route of 
infection. 
 Using our model of transmission we modeled both short-term and long-term transmission 
scenarios. Upon testing the short-term transmission potential of WT and ∆csgD Salmonella 
Typhimurium we observed no difference in their abilities to transmit to naive mice (Figure 30). 
All of the naive mice were colonized and infected by Salmonella, regardless of the strain, and at 
identical rates. Thinking that a difference in transmission would only become apparent in a 
prolonged scenario, we tested the long-term transmission potential of both WT and ∆csgD 
Salmonella Typhimurium as well (Figure 32). Again, we saw no difference in the ability of these 
strains to infect naive mice, suggesting that CsgD was not vital in the transmission process as it 
existed in our model. Recent work has demonstrated that a population of Salmonella 
Typhimurium splits into both planktonic cells and multicellular aggregates and that this process 
involves the bistable expression of csgD 98. WT Salmonella Typhimurium differentiates into two 
distinct phenotypes; one phenotype (planktonic cells) primed for host invasion and the other 
(multicellular aggregates) primed for environmental persistence. The csgD mutant, not 
demonstrating the aggregative phenotype, demonstrated a phenotype resembling the WT 
planktonic cells. As both populations would be primed for host invasion and virulence, it may 
not be surprising that we did not observe a difference in short-term transmission. We also did not 
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observe a large difference in the recovery of WT Salmonella and the csgD mutant from fecal 
pellets after a period of 5 weeks (Figure 22), suggesting the lack of difference between the two 
strains in long-term transmission was also not surprising. However, the number of mice used in 
these transmission experiments was not large, meaning that it is difficult to draw firm 
conclusions. Subsequent experiments should be performed with larger groups of mice so that 
stronger conclusions could be drawn; our initial plans for this transmission model involved a 
total number of 50 mice per experiment in order to be able to discern significance from the data. 
Some compromise between the ease of performing such transmission experiments and the power 
of the results would need to be found. In the long-term transmission experiment we utilized 10 
mice split into 2 groups. In previous trials we had used upwards of 20 mice in order to strengthen 
our results and ensure significance could be found. Depending on the number of different 
exposures (i.e. whether each cage receives the same treatment or not) it would be beneficial to 
have at least 3 cages of 5 mice per treatment in the future; a modified long-term transmission 
experiment would therefore include at least 15 mice. Performing experiments such as these 
would strengthen the results obtained from our model and help to solidify the conclusions that 
we could draw. 
5.2 Future work  
Other uses for our model of transmission remain. The gene shdA, encoding a fibronectin- 
and collagen-binding effector, has been implicated in regulating the shedding of Salmonella from 
warm-blooded hosts and is another potential target related to transmission 57. ∆shdA mutants 
experienced significantly reduced quantity and duration of shedding from murine hosts in a 
typhoid model of infection, while having no impact on the levels of colonization 87. It was also 
found to be absent in S. enterica subspecies other than subspecies enterica, who typically have 
an expanded host range 87. Expression of shdA was only detected in vivo, and not when 
Salmonella were grown in liquid culture 57. This suggests that it plays a role in the host-to-host 
transmission of Salmonella in serovars that are considered host-generalists. MisL is another 
fibronectin-binding protein that has been observed to play a role in the shedding of Salmonella. 
Similar to shdA, ∆misL mutants were shed from mice at reduced rates and the expression of misL 
was not detected when grown in standard laboratory broth 42. That both ShdA and MisL are 
implicated in the binding of extracellular components like fibronectin and collagen suggests that 
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their role in shedding may involve adherence to the intestinal wall of a host, ensuring that 
Salmonella are able to effectively persist in the intestinal tract 106. Their apparent importance in 
the shedding of Salmonella suggests that they may play a role in the transmission process as 
well, meaning they are likely candidates for testing in our model. ∆shdA and ∆misL mutants 
could be tested against the wild-type in our transmission model, and the impact of these 
mutations on transmission could be observed.  
Now that our transmission model is established, it is also possible to also begin testing 
other conditions under which transmission may occur, and whether or not it would be possible to 
view the differences between strains. Using the model we attempted to mimic both short- and 
long-term transmission scenarios. In our vision of long-term transmission we tested the effects of 
a prolonged period of desiccation on the ability of both WT and an isogenic ∆csgD strain of 
Salmonella to transmit to naive mice. In reality, other environmental stresses and conditions 
would be present and exerting survival pressures on the bacteria. As mentioned in in Section 
1.2.3, Salmonella biofilms have been shown to provide increased resistance to other non-host 
conditions as well. An immediate application for our model as it exists would be to adapt the 
long-term transmission experiment for alternate environmental stresses. Fluctuations in pH, 
temperature and nutrient availability could all be introduced to mimic an environmental situation 
where the resistance properties of biofilms could be beneficial. It is possible that the increased 
persistence afforded by a biofilm could lead to more efficient transmission after encountering 
adverse environmental conditions such as these. Alternatively, it would also be possible to 
examine alternate methods of transmission. As demonstrated in Section 1.1.2, water sources that 
have become contaminated with Salmonella, often from fecal shedding, are an important 
environmental reservoir of these bacteria. It is possible that the introduction of an environmental 
stage involving a period of survival in water would lead to differences in the ability of 
Salmonella to transmit. Instead of delivering Salmonella as an oral challenge or through 
contaminated fecal pellets we could inoculate the water supply of a cage of mice with a specified 
quantity of both WT and ∆csgD Salmonella. It would also be possible to “contaminate” the water 
supplies using fecal pellets that we had collected previously. Other experiments could also 
involve altering the types of Salmonella delivered to the mice. Competing differentiated WT 
Salmonella populations (ie. planktonic and aggregative) rather than different mutant strains could 
be performed by contaminating fecal pellets with either planktonic or aggregated population of 
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Salmonella and left desiccated for a period of time. The appearance of a transmission difference 
in these subpopulations would suggest a role for the aggregative phenotype and biofilm 
formation in persistence and survival through differences in a single population of bacteria. 
Situations like these would adapt our transmission model to mimic other potential transmission 
scenarios. 
In our model, we typically observed all-or-nothing transmission efficiency; in all cases, 
either all of the mice in a group became infected with Salmonella or no mice did. One of the 
concerns we had in using streptomycin treatment was that it may lower the barrier of entry for a 
pathogen to such a degree that even avirulent pathogens could successfully infect a mouse due its 
lack of colonization resistance. It has been demonstrated that intestinal inflammation is sufficient 
to enhance the colonization of the murine gut by avirulent Salmonella strains (such as strains 
lacking the two virulence-associated T3SS’s) that would be unable to colonize a typical mouse 
intestine 136; it has also been shown that treatment with streptomycin is sufficient to cause 
inflammation in the murine gut 134. It is possible that this was sufficient to reduce the impact of 
the ∆csgD mutation on transmission. Other methods that disrupt the microbiota in a less drastic 
manner could potentially bring the benefits of efficient Salmonella colonization while retaining 
some measure of colonization resistance to prevent severely attenuated pathogens from 
colonizing the intestine. One method that could accomplish this is the use of mice with a low-
complexity microbiota (LCM), which consists of an altered microbiota of 8 strains typically 
found in the rodent intestine (i.e. Bacteroides spp., Clostridium spp., Lactobacilli etc.) 135. It has 
been shown that LCM mice are colonized by Salmonella Typhimurium at similar levels to 
conventional mice (mice with a conventional microbiota) that have been pre-treated with 
streptomycin 135. An avirulent mutant was able to colonize the intestine of LCM mice, but was 
unable to cause intestinal inflammation and disease. It is possible that by using other techniques 
which aim to reduce the colonization resistance of mice in less drastic methods it would be 
possible to increase the sensitivity of our model, and be able to observe degrees of transmission 
efficiency rather than an all-or-nothing response. Alternatively, it is also possible that the large 
quantities of streptomycin given to the mice in each trial to ensure efficient shedding persisted at 
high levels for the duration of the experiment and impacted the growth and survival of our 
reporter strains. Viable bacteria did, however, continue to be shed from the mice throughout the 
course of our experiments, suggesting that this would not likely be a significant problem. Further 
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developing alternative methods that do not utilize streptomycin would help to allay any concerns 
regarding the survival of our reporter strains in a mouse that had been pre-treated with 
streptomycin. 
5.3 Conclusions 
The establishment of our transmission model means that subsequent studies examining 
the role of specific genetic factors in the transmission process can be performed. It is possible to 
test other individual genes, other transmission methods as well as adapting the model to support 
high throughput methods such as Tn-seq, allowing large portions of the Salmonella genome to be 
tested in transmission at once. Alternatively, utilizing mice from different genetic backgrounds 
could test the role of host factors and the immune response in transmission. Using a modified 
Tn7 transposition system we were able to generate a modular system allowing for the generation 
of a variety of Salmonella reporter strains. We confirmed previous reports that pre-treating mice 
with streptomycin prior to challenge with Salmonella increases the levels of bacterial shedding, 
and we characterized the shedding characteristics of mice challenged with our reporter strains. 
Using mice pre-treated with streptomycin, we also demonstrated that highly efficient 
transmission could occur from seeder to naive mice. Finally, we demonstrated that Salmonella 
Typhimurium ∆csgD mutants were not deficient in short- or long-term transmission in our model 
The studies performed here helped lay the foundations for subsequent transmission experiments 
examining the role of genetic elements in the Salmonella genome. 
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APPENDIX A 
PRIMERS/OLIGONUCLEOTIDES USED IN THIS STUDY 
 
Primer name Nucleotide sequence (5’ à  3’) Function 
glmSdetectFOR AACCACCCGTTCAGGCTGGCTA Confirmation of successful 
chromosomal insertion glmSdetectREV ACGTTGACCAGCCGCGTAAC 
pCS26_Pac_FOR GATCTGCGATTCTGATAAC PCR amplify the luciferase 
construct from pCS26 pCS26_Pac_REV GGGCTAGTCAATGATAATTAC 
pZE05 CCAGCTGGCAATTCCGA PCR amplify promoter region 
of pCS26 pZE06 AATCATCACTTTCGGGAA 
Sac_Pac_Kpn1 CTTAATTAAGGTAC Generate PacI polylinker for 
pUC18R6K mini-Tn7 Sac_Pac_Kpn2 CTTAATTAAGAGCT 
sig70-16-10c2F TCGAGAATAATTCTTTACATTTATGCTT CCGGCTCGTATAATACGTGCAATTG Generate phosphorylated 
sig70c10 promoter 
sig70-16-10c2R GATCCAATTGCACGTATTATACGAGCC GGAAGCATAAATGTAAAGAATTATTC 
sig70-16-35c2F TCGAGAATAATTCTTGACATTTATGCT TCCGGCTCGTATTCTACGTGCAATTG Generate phosphorylated 
sig70c35 promoter 
sig70-16-35c2R GATCCAATTGCACGTAGAATACGAGCC GGAAGCATAAATGTCAAGAATTATTC 
TetExtractFor2 GATCGAATTCTCATGTTTGACA PCR amplify TetR gene from 
pACYC184 TetExtractRev2 GATCCTGCAGAGGGTTGGTTTG 
 
 
 
 
Table 4: Primer/oligonucleotide used in this study. A list of all the primers and oligonucleotides used 
over the course of this study, with sequence information and a description of their purpose. Important 
restriction sites are underlined. 
 
